CELLETS® 200

(200-355 µm)

CELLETS® 200 is a subtype of pellets made of microcrystalline cellulose. The size ranges from 200 µm to 355 µm. Find more product information and technical specifications.

The effect of administration media on palatability and ease of swallowing of multiparticulate formulations

Abstract

Multiparticulate formulations based on pellets, granules or beads, could be advantageous for paediatrics, geriatrics and patients with swallowing difficulties. However, these formulations may require suitable administration media to facilitate administration. The aim of this work was to investigate the effect of administration media properties on palatability and ease of swallowing of multiparticulates. A range of vehicles were developed using xanthan gum (XG) and carboxymethyl cellulose (CMC) as model hydrocolloids. Such vehicles were prepared at three consistency levels (Level 1 – ‘syrup’, Level 2 – ‘custard’ and Level 3 – ‘pudding’) to investigate the effect of viscosity on their performance as administration media. A randomised, single-blind sensory evaluation study was carried out in thirty healthy adult volunteers using microcrystalline cellulose pellets as model multiparticulates, dispersed in the hydrogels (and water as control) at a concentration of 250 mg in 5 ml. Samples were evaluated using 5-point scales. The use of hydrogels as administration media improved a range of sample attributes compared to water formulations, including appearance, taste, mouthfeel, ease of swallowing and residue in the mouth (all improved by ca. 0,5 points) and oral grittiness perception (improved by ca. 1 point). Polymeric hydrogels thickened to medium consistency (Level 2, XG 0.5% and CMC 1.0% w/v) demonstrated the best performance.

Reference

Article: “The effect of administration media on palatability and ease of swallowing of multiparticulate formulations”

Authors: Felipe L. Lopez, Terry B. Ernest, Mine Orlu, and Catherine Tuleu.

First published: International Journal of Pharmaceutics 2018, 551(1–2) 67-75; https://doi.org/10.1016/j.ijpharm.2018.08.021

1. Introduction

Multiparticulate formulations, in the form of pellets, granules or beads, offer a range of advantages over conventional tablets and capsules, such as ease of swallowing, flexible dose titration, and suitability for taste-masking and controlled-release (Lopez et al., 2015). They are considered a flexible solid dosage form for the delivery of drugs to a broad range of patients, including paediatrics, geriatrics and patients with swallowing difficulties. However, previous studies suggest that grittiness and rough mouthfeel perception might be a barrier to palatability and patient acceptability (Kimura et al., 2015, Lopez et al., 2018, Lopez et al., 2016). A potential solution to overcome palatability and acceptability issues could be co-administration with a suitable vehicle (i.e. sprinkle), which could help to conceal the presence of multiparticulates. Some drug products that contain multiparticulates within a capsule or sachet indicate in the labelling that the internal beads can be sprinkled on soft foods for their administration (FDA, 2012). Commercial examples include Depakote® sprinkle capsules (divalproex sodium), Creon® capsules (pancrelipase), Granupas® gastro-resistant granules in sachets (para-aminosalicylic acid) and Cipla’s lopinavir/ritonavir pellets in capsules (Hanning et al., 2016, Ternik et al., 2017). Typical vehicles recommended for products labelled for sprinkle include apple sauce and yogurt that provide both flavour and viscosity to facilitate administration and improve patient acceptability (Ternik et al., 2017).

Studies comparing sprinkle formulations to liquid dosage forms in children have commonly showed preference for the solid over the liquid form. A range of studies showed acceptance of iron supplement sprinkles and preference for these compared to oral drops in children with anaemia (Adu-Afarwuah et al., 2008, Geltman et al., 2009, Zlotkin et al., 2003). Likewise, studies involving children suffering from epilepsy consistently showed preference for sprinkle formulations over syrup (Cloyd et al., 1992, Motte et al., 2005, Verrotti et al., 2012). In a recent study, children showed preference for sprinkles over syrup after 12-week antiretroviral therapy; 72% of children below 12 months and 64% of children between 1 and 4 years preferred the multiparticulate dosage form. For those preferring syrups, key issues with sprinkles were problems masking the pellets with food and food refusal, and concerns about not giving the whole dose. However, multiparticulates overcome the storing and transporting issues of syrups (Kekitiinwa et al., 2016).

Medicines are known to be mixed with liquid and semi-solid foodstuff to allow administration in clinical practice (Akram and Mullen, 2015, Akram and Mullen, 2012). However, this is not without the risks that mixing medication with foodstuff could alter bioavailability and introduce poor control over dose intake (EMA, 2013). Therefore, when co-administration of medicines and foodstuff is recommended in the package leaflet, the potential impact on patient acceptability, dosing accuracy, compatibility and drug bioavailability of the proposed vehicle(s) must be investigated (EMA, 2013). This task becomes very impractical when medicines can be mixed with a range of foods with different composition and physical properties (e.g. rheology, pH, ionic strength) (Kersten et al., 2016). The development of a standard pharmaceutical vehicle, rationally designed and fit for purpose, could facilitate such investigations. This vehicle could be manufactured by industry and provided with the finished drug product (although this would increase the overall cost of the product) or it could be compounded in a pharmacy (Kluk and Sznitowska, 2014). Investigation into swallowing aids for the administration of oral solid formulations have been the focus of previous research, with some products already in the market in the form of sprays, pastes or jellies (Bunupuradah et al., 2006, Diamond and Lavallee, 2010, Yoshida et al., 2011).

The rheological properties of the administration media require special consideration. Thick fluids are known to exhibit prolonged oral transit times than thinner fluids, which can be used in the management of patient with dysphagia (Soares et al., 2015). Conversely, greater efforts are required to manipulate in the mouth and swallow thick fluids compared to thin ones (Ong et al., 2018, Steele et al., 2015). Consequently, overly thick liquids may increase the risk of post-swallow residue in the mouth and pharynx, especially for patients with reduced tongue or pharyngeal muscle strength (Steele et al., 2015). Newtonian fluids have also been reported to require greater effort in oral processing and swallowing than shear thinning fluids (Steele et al., 2015). In addition, the rheology of the vehicle also affects its palatability, with organoleptic attributes often reported to worsen as the consistency of the fluid increases (Garcia et al., 2005, Ong et al., 2018). Therefore, it is imperative that the rheological and sensory properties of the vehicle are adequately characterised.

The use of a suitable vehicle could facilitate administration of multiparticulates by preventing fast sedimentation, improving palatability and reducing the risk of aspiration or choking often associated with this dosage form design (Walsh et al., 2018). Development of media for the administration of multiparticulates and evaluation of its effect on palatability has been the focus of two recent studies (Kluk and Sznitowska, 2014, Lopez et al., 2016), both of which concluded that the use of polymeric hydrogels as administration media could help conceal the presence of particles, reducing oral grittiness perception. However, both studies focussed on a swirl and spit methodology, which overlooks other important sample attributes such as ease of swallowing. Moreover, neither of those studies investigated the palatability of the liquid vehicles alone, which limited their understanding on the effect of the palatability of the vehicle on the overall palatability and acceptability of the final formulations.

The aim of this work was to develop liquid vehicles for the administration of multiparticulates and to investigate the effect of the administration media properties on palatability and ease of swallowing of multiparticulate formulations. Administration media were developed using xanthan gum (XG) and carboxymethyl cellulose (CMC) as model hydrocolloids. The rheological properties of the hydrocolloids were characterised to investigate the effect of consistency and shear thinning behaviour on their performance as administration media. Palatability attributes and ease of swallowing of the vehicles alone and formulations containing model multiparticulates were evaluated in healthy volunteers.

2. Materials and methods

2.1. Materials

Microcrystalline cellulose pellets (CELLETS® 200 and CELLETS® 700) were provided by Pharmatrans Sanaq (Basel, Switzerland). Xanthan gum (“XG”, Xantural 180, 1% gum in 1% KCl aqueous solution: 1200–1600 cP) was supplied by CP Kelco (Leatherhead, Surrey, UK); sodium carboxymethyl-cellulose (“CMC”, Blanose 7HF-PH, 1% aqueous solution: 1500–2500 cP) was provided by Ashland (Covington, Kentucky, USA); and vanillin was procured from Sigma-Aldrich (Irvine, Ayrshire, UK).

2.2. Preparation of administration media

Polymeric hydrogels in the range of 0.15–1.50% (w/v) were prepared by slow addition of hydrophilic polymer (XG or CMC) into 100 ml of water under continuous stirring at room temperature. Previous research indicate that some hydrocolloids may impart a noticeable foreign taste or off-flavour to water and other liquid vehicles (Matta et al., 2006, Ong et al., 2018, Pelletier, 1997, Saha and Bhattacharya, 2010). For this reason, a small amount of vanillin (0.1% w/v) was added to mask any potential taste and smell of the polymers which could negatively impact results. Samples were left stirring overnight to ensure complete polymer hydration and stored in the refrigerator at 5 ± 0.5 °C. Samples were allowed to equilibrate to room temperature before testing.

For the sensory evaluation study, the viscosity of the XG and CMC vehicles were targeted to meet the International Dysphagia Diet Standardisation Initiative (IDDSI) descriptors (Cichero et al., 2017, IDDSI, 2015). According to this framework, Level 1 fluids are “thicker than water but flow through a teat/nipple and straw”, Level 2 fluids “require effort to drink through a straw and flow quickly off a spoon” and Level 3 fluids are “difficult to suck through a straw and pour slowly off a spoon”.

2.3. Rheological characterisation

A Bohlin CVO rotational rheometer system (Malvern Instruments Ltd, Malvern, UK) was used to investigate the flow properties of the samples using a cone and plate geometry (40 mm diameter, 4° angle; gap size adjusted to 250 µm). A shear sweep measurement mode was employed, whereby the shear rate of the sample was advanced across the range of 0.1–200 s−1, with ascendant logarithmic progression. The temperature of the samples was maintained at 25 ± 0.2 °C throughout testing. This procedure was repeated three times for each sample.

The resulting data (shear rate vs. shear stress) was fitted to the power law model (Eq. (1)) to describe the flow properties of the samples:(1)σ=Kγnwhere σ is the shear stress (Pa), γ is the shear rate (1/s), K is the consistency index (Pas), and n is the flow behaviour index (dimensionless). The consistency index (K) corresponds to the viscosity at a shear rate of 1 s−1; whereas the flow behaviour index (n) provides an indication of the deformation behaviour, where a value of 1 indicates Newtonian behaviour, 0–1 indicates shear-thinning behaviour and values greater than 1 indicate shear-thickening (O’Leary et al., 2010). In addition, the apparent viscosity at 50 s−1 (ƞ at 50 s−1), a reference shear rate for oral processing and swallowing, and the apparent viscosity at 0.1 s−1 (ƞ at 0.1 s−1), a reference shear rate of the sample at rest, were measured by the rheometer along the ascendant shear ramp.

2.4. Sedimentation experiments

The ability of the administration media to maintain multiparticulates in suspension was calculated based on sedimentation experiments. A sample containing 500 mg of CELLETS® and 50 ml of administration media was filled into a 50-ml graduated plastic tube. The tube was turned upside down until homogeneous dispersion of the particles. Then, the sample was left standing and the time taken for CELLETS® to clarify the top 15 ml of the dispersant (approximately one third of the media volume) was determined. This experiment was adapted from that described by Kluk and co-workers (Kluk and Sznitowska, 2014). Experiments were repeated using multiparticulates of two extreme particle sizes, CELLETS® 200 (200–355 µm) and CELLETS® 700 (700–1000 µm), to account for the effect of particle size on sedimentation. The experiment was conducted in triplicate.

2.5. Sensory evaluation study

2.5.1. Study design

Thirty healthy adult volunteers (aged 19–33 years, average 23.2 ± 4.4 years; 21 females) were enrolled in a randomised, single-blind, single-centre, 3-treatment, crossover sensory evaluation. The study was approved by UCL Research Ethics Committee (Project ID: 4612-011). All participants received a detailed information sheet and provided written consent to participate in the study. The study was conducted in three sessions taken place on three separate days. On each day, participants tested samples of liquid vehicles without particles (T1: ‘no particles’), with 200–355 µm particles (T2: ‘smaller particles’) and with 700–1000 µm particles (T3: ‘larger particles’). Participants were divided into six groups to ensure that all possible sequence orders between treatments were considered. In each session, participants were handed eight samples, including XG and CMC samples and water as a control (Table 1), in a randomised order.

table-1

Table 1. List of liquid vehicles assessed in sensory evaluation experiments.

For samples containing multiparticulates, 250 mg of solid particles were pre-dispersed in the administration media (approximately 3 ml, for a total volume of 5 ml) using a spatula immediately before administration. Microcrystalline cellulose pellets used in this investigation were non-disintegrating in water or in the mouth. Samples were provided onto 5-ml plastic medicine spoons that were handed to participants of the study. During the evaluation of the samples, participants had free access to spring water to complete sample intake and clean their palate. To minimise subject discomfort and carryover effect 5–10-minute intervals were respected between samples.

2.5.2. Evaluation tool and outcome measures

A digitalized questionnaire (Qualtrics.com) was used for data collection. Immediately after swallowing the sample, volunteers were asked to rate several sample attributes, including appearance, ease of swallowing, mouth-feel and taste, using a 5-point hedonic scale (1 – extremely liked, 5 – extremely disliked). In addition, the feeling of particles in the mouth during sample intake (i.e. grittiness perception) and the feeling of particles in the mouth after sample intake and after rinsing their mouth with water (i.e. residue in mouth) was assessed using a 5-point magnitude scale (1 – not perceptible, 5 – extremely perceptible). Participants could also provide voluntary feedback of each sample attribute using their own words.

2.5.3. Data analysis

The different categories of the 5-point scales were assigned numeric scores (1–5) from lowest to highest stimuli perception, respectively. Statistical analysis was performed using the non-parametric Kruskal-Wallis one-way analysis of variance followed by Dunn’s test as post hoc for pairwise comparison, both with a 95% confidence level. Minitab 17 (Minitab Inc., State College, Pennsylvania, USA) was used for data analysis.

3. Results and discussion

3.1. Development of administration media for multiparticulates

3.1.1. Rheological properties

The rheological properties of the administration media require especial attention as these will have an impact on several critical quality attributes, such as suspendability and palatability (particularly appearance and mouth-feel). XG and CMC were selected as model excipients to develop polymeric hydrogels for the administration of multiparticulates, being Generally Regarded As Safe (GRAS) excipients commonly used in oral formulations.

The rheological properties of XG and CMC hydrogels were investigated as a function of the hydrocolloid concentration (Table 2). The consistency index of XG and CMC-based polymeric hydrogels increased as the hydrocolloid concentration increased, as it can be expected. The increase in viscosity was more pronounced for XG than it was for CMC, revealing the higher ‘thickening power’ of XG. In addition, XG hydrogels exhibited a strong shear thinning behaviour whereas CMC hydrogels showed a much lower degree of shear thinning; the flow behaviour index (n-value) of XG-based hydrogels was lower than that of CMC-based hydrogels throughout the range of concentrations tested.

table-2

Table 2. Rheological characteristics of XG and CMC hydrogels prepared at concentrations 0.15–1.50% w/v.

The contrasting rheological characteristics of XG and CMC made them ideal candidates to investigate the effect of shear thinning behaviour on their performance as administration media for the administration of multiparticulates. Previous research indicate that Newtonian fluids require greater effort in oral processing and swallowing than shear thinning fluids (Steele et al., 2015). However, it could be hypothesised that shear thinning fluids would be less effective in ‘masking’ the presence of particles since the viscosity of these fluids will decrease under the relatively high shear rates experienced during oral processing (50–300 s−1) (Steele et al., 2015).

3.1.2. Ability to maintain multiparticulates in suspension

An ideal vehicle should be able to maintain multiparticulates in suspension from dispersion of the particles in the media until administration. Sedimentation time of multiparticulates in polymeric hydrogels was determined by measuring the time lapse between homogeneous dispersion of multiparticulates and clearance of the top layer of the liquid vehicle. Results of sedimentation time as a function of the media viscosity are summarised in Table 3. The time needed for manipulation and administration of a medicine is usually less than 5 min but can take longer than 10 min in some cases (Ruiz et al., 2016), thus appropriate administration media should maintain multiparticulates in suspension for at least 10–15 min.

table-3

Table 3. Sedimentation time (minutes) of CELLETS® 200 and CELLETS® 700 in XG and CMC hydrogels.

Sedimentation time increased with increasing viscosity of the media and decreased with increasing size of the multiparticulates, in accordance to Stoke’s law. XG hydrogels prepared at 0.25% w/v would be sufficient to maintain both 200–355 and 700–1000 µm particles in suspension for at least 10–15 min, whereas a higher concentration of CMC (1.00% w/v) would be required to maintain the larger particles in suspension for the same time. The lower concentration of XG required to maintain multiparticulates in suspension could be expected based on its stronger thickening power and its shear thinning character, which means that the viscosity of XG hydrogels at low shear rates (i.e. shear rates relevant during sedimentation) is higher than that of CMC hydrogels.

3.2. Sensory evaluation studies

3.2.1. Liquid vehicles without multiparticulates

Participants of the sensory evaluation study tested liquid vehicles without multiparticulates in one of the three sessions of the study. The analysis of liquid vehicles without multiparticulates was performed in order to gain fundamental understanding of the properties of the liquid vehicles, such as appearance, mouthfeel, taste and ease of swallowing.

All samples evaluated received average appearance ratings in the neutral to positive range of the scale, except for XG L3 (average appearance rating = 3.17). According to participants responses to hedonic scales, the appearance of XG hydrogels was worse than the appearance of water and CMC hydrogels (p < 0.001), as shown in Fig. 1. This was adscribed to the opaque appearance of XG hydrogels (in contrast with the transparent aspect of water and CMC hydrogels), as supported by anecdotal feedback provided by the participants: e.g. “I personally prefer when the sample is limpid, this one was a bit opaque and it gives you an idea of dirt” (Participant 11, XG L3). Appearance ratings worsened as the consistency level increased. This indicates that the appearance of very thick samples (which retain their shape when placed on a spoon) was considered less appealing than thinner fluids.

swallowing of multiparticulate formulations_fig-1

Fig. 1. Interval plot for appearance, mouthfeel, taste and ease of swallowing of different liquid vehicles. Markers represent the population mean for the hedonic ratings (where 1 is the best possible rating and 5 is the worst possible rating) and bars show the 95% CI for the mean. Water + v. represents water to which 0.1% w/v vanillin was added; the consistency level of XG and CMC hydrogels is described as L1 (Level1), L2 (Level 2) and L3 (Level 3).

The taste of all liquid vehicles evaluated received average ratings between 2 and 3 (range: 2.33–2.63; XG L1 – Water), which indicates acceptable neutral taste (Fig. 1). The very small differences between samples confirmed that the level of vanillin used was appropriate to mask any potential foreign taste from the polymer without having a significant impact on results (as it was intended). However, the fact that average ratings for taste were closer to the centre of the scale than to the positive end of the scale may indicate participants’ expectations of a more intense, sweetened or flavoured taste for samples intended as a medicinal product. This was reinforced by voluntary feedback; e.g. “if this had added sugar/sweetener it would be a more enjoyable medicine to take” (P05, CMC L3).

Mouthfeel ratings of XG and CMC hydrogels worsened as the consistency of the sample increased, revealing preference for thinner vehicles (Fig. 1). This is consistent with previous research which reported that thinner fluids are perceived as less viscous, less adhesive and easier to manipulate in the mouth than thicker fluids (Ong et al., 2018). However, all samples received average ratings in the neutral to positive range of the scale (range: 1.67–2.90), suggesting all vehicles prepared had an acceptable mouthfeel to be used as media for the administration of multiparticulates. CMC hydrogels received slighly worse mouthfeel ratings than XG samples, which was attributed to a “greasy” or “oily” feeling in the mouth, as reported by the volunteers. The mouth-coating texture of CMC hydrogels has been reported in previous research and attributed to its low degree of shear thinning (high n-value) (Cho et al., 2015, Szczesniak and Farkas, 1962). On the contrary, xanthan gum samples have been perceived as less adhesive and easier to manipulate in the mouth (Ong et al., 2018). Nevertheless, mouthfeel differences between XG and CMC vehicles were not statistically significant, despite their contrasting rheological profiles. The inability to clearly identify preference between samples can be explained by consumers, including patients, having different criteria for personal preferences (Matta et al., 2006).

All samples evaluated were considered ‘easy to swallow’ by healthy volunteers, receiving average ratings in the neutral to positive range of the scale (range: 1.07–2.57). However, samples were considered relatively more difficult to swallow as the consistency level increased (p < 0.001), as depicted in Fig. 1. This can be attributed to the greater effort required to convey thicker fluids through the oral cavity and greater effort required for the throat muscles to swallow thicker fluids (Ong et al., 2018). In their open-ended feedback, participants described the need to swallow repetitively to achieve full ingestion of thicker samples; e.g. “the sample is very viscous and is difficult to swallow, it remains in my mouth after swallowing a few times” (P22, CMC L3). This is in line with previous research as thicker liquids have been shown to increase the risk of post-swallow residue in the mouth and pharynx (Steele et al., 2015). It is also well established that fluids with higher viscosity exhibit prolonged oral transit times as compared to thinner fluids such as water (Soares et al., 2015). Moreover, the ratings of ease of swallowing indicate that XG hydrogels were slightly easier to swallow than CMC hydrogels (p < 0.018), which was supported by anecdotal feedback; e.g. “this sample (CMC L2) is more difficult than the previous one (XG L2) in swallowing it as a whole, as it remains in my mouth after the first swallow” (P10, CMC L2). This can be explained by the stronger shear thinning behaviour of XG hydrogels. Shear thinning fluids can be expected to be easier to swallow due to lower resistance to flow under shear (Ong et al., 2018, Steele et al., 2015).

3.2.2. Multiparticulates dispersed in liquid vehicles

The appearance of multiparticulate samples dispersed in different vehicles received average ratings around the neutral range of the scale (range: 2.70–3.40), as shown in Fig. 2. The size of the multiparticulates had no influence on the ratings of appearance (p = 0.074), whereas the vehicle used had a significant impact on the appearance of the final formulation (p < 0.001). The appearance of samples dispersed in polymeric hydrogels (2.96 for XG and 2.77 for CMC hydrogels, on average) was considered better than that of samples dispersed in water (3.33 with and 3.40 without vanillin). This was explained by the more homogenous appearance of samples dispersed in thickened vehicles as compared to multiparticulates dispersed in water. Multiparticulates precipitated very quickly in water, due to its very low viscosity, leading to heterogenous samples with particles settled down on the bottom of the spoon. On the contrary, CELLETS® remained homogeneously dispersed in thicker hydrogels, which was considered a positive feature by the volunteers. Moreover, samples prepared in XG vehicles thickened to the highest consistency were rated more negatively than samples dispersed in other hydrogels, which can be expected based on the negative ratings of appearance received by this vehicle when evaluated on its own.

swallowing of multiparticulate formulations_fig-2

Fig. 2. Interval plot for appearance, taste, mouthfeel and ease of swallowing as a function of the vehicle used as suspending media and the size of the dispersed multiparticulates: 200–355 µm (CELLETS® 200) or 700–1000 µm (CELLETS® 700). Markers represent the population mean for the hedonic ratings (where 1 is the best possible rating and 5 is the worst possible rating) and bars show the 95% CI for the mean. Water + v. represents water to which 0.1% w/v vanillin was added; the consistency level of XG and CMC hydrogels is described as L1 (Level1), L2 (Level 2) and L3 (Level 3).

The taste of the samples worsened when multiparticulates where added into the formulation and when the multiparticulate size increased (Fig. 2); from 2.44 on average without presence of multiparticulates to 2.63 and 2.89 on average with smaller and larger multiparticulates, respectively. In addition, the taste of formulations with vanilla flavour was deemed better than the taste of samples prepared with pure water (p < 0.001). On the contrary, no significant differences were found between XG and CMC samples in terms of taste which, again, confirmed the successful masking of any potential inherent taste of the polymer by addition of a small quantity of vanillin. Although microcrystalline cellulose pellets are expected to be tasteless, negative taste ratings in hedonic scales have been previously reported and attributed to the poor mouthfeel of the formulation (Lopez et al., 2018). This can be explained by a common cognitive bias in sensory evaluation by which perception of a salient attribute influences the ratings of other (independent) sample attributes (Clark and Lawless, 1994).

The mouthfeel of multiparticulates dispersed in liquid vehicles also received average ratings around the neutral range of the scale (Fig. 2). Both the size of the multiparticulates and the vehicle used to disperse them had a significant impact on mouthfeel of the final formulation (p = 0.001 and p < 0.001, for size and vehicle, respectively). The mouthfeel of samples containing smaller multiparticulates was on average 0.30 points better than that of samples containing larger multiparticulates. An increasing grittiness sensation or rough mouthfeel with increasing size of the multiparticulates have also been reported on previous studies (Kimura et al., 2015, Kluk and Sznitowska, 2014, Lopez et al., 2018, Lopez et al., 2016). In terms of the vehicle used, participants showed preference for samples dispersed in thickened vehicles over samples dispersed in water. In addition, participants preferred the samples with low and middle-range consistencies (Level 1 and Level 2) over the extremely thick ones (Level 3). According to the participants of the study, those samples achieved a good balance by “concealing the presence of particles in the mouth” but not being too thick (which has a detrimental impact on mouthfeel). Samples thickened to Level 1 and Level 2 consistencies were rated on average 0.62 and 0.54 points better than water, respectively, whereas samples with Level 3 consistency were rated only 0.34 points better than water, on average.

As depicted in Fig. 2, swallowing of multiparticulates was considered more difficult with increasing particle size, from 2.36 on average for smaller multiparticulates to 2.91 on average for larger multiparticulates (p < 0.001). Multiparticulates dispersed in polymeric hydrogels were easier to swallow than multiparticulates dispersed in water (by approximately 0.50 points), irrespectively of the size of the particles. Both XG and CMC hydrogels were similarly efficient in facilitating swallowing of the multiparticulates (2.52 and 2.49 on average, respectively). Therefore, no significant differences were found between XG and CMC hydrogels in terms of ease of swallowing when administered with multiparticulates, despite their different rheological properties and the differences found when administered without multiparticulates. This might indicate that the sensory properties of the samples were dominated by the presence of particles in suspension at relatively high concentration (Mueller et al., 2010), thus differences between vehicles became negligible. The rheological properties of the samples could be dramatically affected by addition of multiparticulates; the inclusion of the solid particles is expected to produce and increase in consistency and in shear thinning behaviour (Mueller et al., 2010). In agreement with the results for mouthfeel perception, participants showed preference for swallowing samples with thin and middle-range consistencies (Levels 1 and 2) as opposed to thicker samples. These samples performed best at “carrying the particles together” as a bolus and “providing cushioning”, facilitating swallowing, while not being too thick to “linger around” in the oral cavity for long. The contrast between samples of different consistency was reported in open-ended responses; e.g.: “the liquid in this sample was too runny and was unable to carry the particles along with it, so the liquid part was consumed first, leaving behind the solid part of the sample” (P02, CELLETS® 200 in Water); or “I feel that this sample has the correct viscosity that is able to hold the particles together and is able to be easily swallowed” (P10, CELLETS® 200 in XG L1).

As discussed above, grittiness perception increased with increasing size of the multiparticulates (p < 0.001) in agreement with previous studies (Kimura et al., 2015, Kluk and Sznitowska, 2014, Lopez et al., 2018, Lopez et al., 2016); samples of smaller multiparticulates obtained an average grittiness score of 2.50 compared to 3.31 scored on average by samples containing larger multiparticulates. The feeling of residual particles in the mouth also increased with increasing size of the multiparticulates, 1.67 on average for CELLETS® 200 compared to 2.14 on average for CELLETS® 700 (Fig. 3). Participants ratings of ‘grittiness perception’ confirmed the results obtained for mouthfeel and ease of swallowing in that polymeric hydrogels masked the presence of multiparticulates. Grittiness perception was lower for polymeric hydrogel formulations than for samples dispersed in water by approximately 1.0 point, on average, both for smaller and larger multiparticulates. This was supported by voluntary feedback; e.g. “without a thick solution to act as a lubricant and carry the particles along with it, the ‘grainy’ feeling was enhanced, making it very unpleasant to take” (P02, CELLETS® 200 in water); compared to samples in thickened vehicles, e.g. “it is viscous, but that masks the overall ‘particles feel’, which is good” (P12, CELLETS® 200 in CMC L2). The use of polymeric hydrogels to disperse multiparticulates also reduced the ‘residue in mouth’, i.e. the feeling of particles in the mouth after swallowing (p < 0.001), for multiparticulates of both sizes evaluated. The residual feeling of particles was reduced by approximately 0.5 points on average when using polymeric hydrogels as vehicles, as compared to water.

swallowing of multiparticulate formulations_fig-3

Fig. 3. Interval plot for grittiness and residue of multiparticulates in mouth after swallowing as a function of the vehicle used as suspending media and the size of the multiparticulates: 200–355 µm (CELLETS® 200) or 700–1000 µm (CELLETS® 700). Markers represent the population mean for the 5-point magnitude scale (where 1 is the lowest possible and 5 is the highest possible intensity of the stimulus) and bars show the 95% CI for the mean. Water + v. represents water to which 0.1% w/v vanillin was added; the consistency level of XG and CMC hydrogels is described as L1 (Level1), L2 (Level 2) and L3 (Level 3).

According to the ratings on the 5-point scale, no significant differences were found between XG and CMC hydrogels in their ability to mask the grittiness of particles, either during sample intake or after swallowing of the samples; although the trend suggests that CMC vehicles performed better when using multiparticulates of larger size. As previously discussed, this indicates that the sensory properties of the samples were dominated by the presence of multiparticulates rather than the shear thinning behaviour of the vehicles. Moreover, no significant differences were found between vehicles thickened to different consistency levels based on scale ratings, although anecdotal feedback indicated that thicker hydrogels performed better than thinner vehicles in terms of masking the presence of particles, e.g. “less thick than other samples, thus I can feel the particles when I swallowed it; need to drink water to remove the particles” (P16, CELLETS® 200 in XG L1). Disagreement between grittiness ratings and voluntary feedback suggests that scale ratings were influenced by the overall appreciation of the sample, an issue commonly encountered in sensory evaluation studies (Clark and Lawless, 1994, Prescott et al., 2011). As the concentration of hydrocolloid in de sample increased, the perception of particles decreased but other organoleptic attributes worsened. As such, mouthfeel and grittiness perception were driven by a balance between those opposing phenomena, which explains the similar ratings obtained by samples of different consistency despite their different organoleptic attributes. These findings highlight the multifactorial nature of palatability and mouthfeel perception which poses a challenge to evaluate sample attributes independently (Clark and Lawless, 1994, Popper et al., 2004, Prescott et al., 2011).

The results of these trial are summarised in Fig. 4, where the radar charts show the mean result for each palatability attribute as a function of the size of the multiparticulates and the administration media (water with vanillin, which was used as a control, was excluded from the graphs to aid clarity). The use of polymeric hydrogels as administration media resulted in an overall improvement of the samples: appearance, taste, mouthfeel, ease of swallowing and residue in the mouth improved by ca. 0.5 points, and oral grittiness perception improved by ca. 1 point. Overall, polymeric hydrogels thickened to medium consistency (Level 2) demonstrated the best performance by virtue of their ability to conceal the grittiness of multiparticulates in the mouth and to aid swallowing of the formulation as a bolus, while maintaining a balanced consistency (not too thick) to ensure appropriate mouthfeel. These findings were in line with previous research in the field in that vehicles of very thick consistency tend to be disliked despite their ability to mask the presence of multiparticulates in the formulation (Kluk and Sznitowska, 2014, Lopez et al., 2016). Further investigation of the physicochemical properties of the samples, such as adhesiveness, ductility and lubrication properties could provide a more rigorous insight into the physical drivers for mouthfeel perception (Stokes et al., 2013). Differences in palatability and acceptability can be expected in different sub-sets of the population (Lopez et al., 2018, Mennella et al., 2012), thus future work should investigate the acceptability of these vehicles in paediatrics and patients with swallowing difficulties, those who could benefit the most from these formulations.

swallowing of multiparticulate formulations_fig-4

Fig. 4. Radar chart for appearance, taste, grittiness, mouthfeel, ease of swallowing and residue of multiparticulates in mouth as a function of the vehicle used as suspending media and the size of the multiparticulates: 200–355 µm (CELLETS® 200) or 700–1000 µm (CELLETS® 700). Each palatability item is described by its population mean for the 5-point scale (where 1 is the lowest possible and 5 is the highest possible intensity of the stimulus). The consistency level of XG and CMC hydrogels is described as L1 (Level1), L2 (Level 2) and L3 (Level 3).

4. Conclusion

The use of hydrogels as administration media for multiparticulates improved a range of sample attributes compared to water formulations, including appearance, taste, mouthfeel, ease of swallowing and grittiness perception during and after sample intake. This improvement was apparent for samples containing multiparticulates of both sizes investigated (those over 200 and those over 700 µm). Polymeric hydrocolloids provided ‘cushioning and lubrication’ of the particles and acted as an effective vehicle by ‘carrying the particles together’, concealing the gritty feeling of the multiparticulates and assisting swallowing. Participants also reported that additional intake of water after administration of the gel formulation was beneficial to facilitate swallowing of the full dose of multiparticulates. Polymeric hydrogels thickened to medium consistency (Level 2, XG 0.5% and CMC 1.0% w/v) were preferred over either thinner or thicker vehicles. A balanced consistency reduced the gritty feeling of multiparticulates while not being overly thick, which would hinder sensory attributes. Meanwhile, differences between XG and CMC hydrogels were minimal despite their opposing shear thinning behaviour. These findings suggest that the consistency of the vehicle was an attribute of greater importance than its shear thinning behaviour. However, XG brings the added value of its strong thickening power, requiring very low concentrations to produce hydrogels of adequate consistency. Results of this study indicate that polymeric hydrogels could be used to improve palatability, facilitate swallowing and enhance patient acceptability of multiparticulate formulation.

5. Author contribution statement

Felipe L. Lopez: Methodology, Investigation, Formal Analysis, Visualization, Writing- Original draft preparation. Terry B. Ernest: Funding Acquisition, Conceptualization, Methodology, Supervision, Writing – Review & Editing. Mine Orlu: Funding Acquisition, Conceptualization, Methodology, Supervision, Writing – Review & Editing. Catherine Tuleu: Funding Acquisition, Conceptualization, Methodology, Validation, Supervision, Writing – Review & Editing.

Acknowledgement

The authors are grateful to the EPSRC for providing funding through a studentship within the CDT in Targeted Therapeutics and Formulation Sciences (EPSRC grant: EP/I01375X/1).

Conflict of interest statement

The authors declare no conflict of interest other than their disclosed affiliations and acknowledged funding.

Appendix A. Supplementary data

Supplementary data associated with this article can be found, in the online version, at https://doi.org/10.1016/j.ijpharm.2018.08.021.

License

Creative Commons license CC BY 4.0.

References

Adu-Afarwuah, S., Lartey, A., Brown, K.H., Zlotkin, S., Briend, A., Dewey, K.G., 2008. Home fortification of complementary foods with micronutrient supplements is well accepted and has positive effects on infant iron status in Ghana. Am. J. Clin. Nutr. 87, 929–938.

Akram, G., Mullen, A.B., 2015. Mixing medication into foodstuffs: identifying the issues for paediatric nurses. Int. J. Nurs. Pract. 21, 125–131. https://doi.org/10.1111/ijn.12222.

Akram, G., Mullen, A.B., 2012. Paediatric nurses’ knowledge and practice of mixing medication into foodstuff. Int. J. Pharm. Pract. 20, 191–198. https://doi.org/10.1111/j.2042-7174.2011.00179.x.

Bunupuradah, T., Wannachai, S., Chuamchaitrakool, A., Intasan, J., Nuchapong, T., Neiss, W., Kramm, K., Pancharoen, C., Burger, D., Ananworanich, J., 2006. Use of tastemasking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals. AIDS Res. Ther. 3, 30. https://doi.org/10.1186/1742-6405-3-30.

Cho, H., Yoo, W., Yoo, B., 2015. In: Effect of NaCl Addition on Rheological Behaviors of Commercial Gum-Based Food Thickener Used for Dysphagia Diets, pp. 137–142. https://doi.org/https://doi.org/10.3746/pnf.2015.20.2.137.

Cichero, J.A.Y., Lam, P., Steele, C.M., Hanson, B., Chen, J., Dantas, R.O., Duivestein, J., Kayashita, J., Lecko, C., Murray, J., Pillay, M., Riquelme, L., Stanschus, S., 2017. Development of international terminology and definitions for texture-modified foods and thickened fluids used in dysphagia management: the IDDSI framework. Dysphagia 32, 293–314. https://doi.org/10.1007/s00455-016-9758-y.

Clark, C., Lawless, H.T., 1994. Limiting response alternatives in time-intensity scaling: an examination of the halo-dumping effect. Chem. Senses 19, 583–594. https://doi.org/10.1093/chemse/19.6.583.

Cloyd, J.C., Kriel, R.L., Jones-Saete, C.M., Ong, B.Y., Jancik, J.T., Remmel, R.P., 1992. Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference. J. Pediatr. 120, 634–638. https://doi.org/10.1016/S0022-3476(05)82496-5.

Diamond, S., Lavallee, D.C., 2010. Experience with a pill-swallowing enhancement aid. Clin. Pediatr. (Phila) 49, 391–393. https://doi.org/10.1177/0009922809355313. EMA, 2013. Guideline on pharmaceutical development of medicines for paediatric use [WWW Document]. URL  http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147002.pdf.

FDA, 2012. Guidance for Industry Size of Beads in Drug Products Labeled for Sprinkle Guidance for Industry Size of Beads in Drug Products Labeled for Sprinkle.

Garcia, J.M., Chambers IV, E., Matta, Z., Clark, M., 2005. Viscosity measurements of nectar- and honey-thick liquids: product, liquid, and time comparisons. Dysphagia 20, 325–335. https://doi.org/10.1007/s00455-005-0034-9.

Geltman, P.L., Hironaka, L.K., Mehta, S.D., Padilla, P., Rodrigues, P., Meyers, A.F., Bauchner, H., 2009. Iron supplementation of low-income infants: a randomized clinical trial of adherence with ferrous fumarate sprinkles versus ferrous sulfate drops. J. Pediatr. 154. https://doi.org/10.1016/j.jpeds.2008.11.003.

Hanning, S.M., Lopez, F.L., Wong, I.C.K., Ernest, T.B., Tuleu, C., Orlu Gul, M., 2016. Patient centric formulations for paediatrics and geriatrics: similarities and differences. Int. J. Pharm. 512, 355–359. https://doi.org/https://doi.org/10.1016/j.ijpharm.2016.03.017.
IDDSI, 2015. Detailed Descriptors, Testing Methods and Evidence – Drinks: Levels 0-4 [WWW Document]. URL http://iddsi.org/framework/.

Kekitiinwa, A., Musiime, V., Thomason, M.J., Mirembe, G., Lallemant, M., Nakalanzi, S., Baptiste, D., Walker, A.S., Gibb, D.M., Judd, A., Judd, A., 2016. Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children. Antiviral Ther. https://doi.org/10.3851/IMP3054.

Kersten, E., Barry, A., Klein, S., 2016. Physicochemical characterisation of fluids and soft foods frequently mixed with oral drug formulations prior to administration to children. Pharmazie 71, 122–127. https://doi.org/10.1691/ph.2016.5145.

Kimura, S., Uchida, S., Kanada, K., Namiki, N., 2015. Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets. Int. J. Pharm. 484, 156–162. https://doi.org/10.1016/j.ijpharm.2015.02.023.

Kluk, A., Sznitowska, M., 2014. Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients. Int. J. Pharm. 460, 228–233.  https://doi.org/10.1016/j.ijpharm.2013.10.052.

Lopez, F.L., Bowles, A., Gul, M.O., Clapham, D., Ernest, T.B., Tuleu, C., 2016. Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers. Eur. J. Pharm. Sci. 92, 156–162. https://doi.org/10.1016/j.ejps.2016.07.006.

Lopez, F.L., Ernest, T.B., Tuleu, C., Gul, M.O., 2015. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opin. Drug Deliv. 12, 1727–1740. https://doi.org/10.1517/17425247.2015.1060218.

Lopez, F.L., Mistry, P., Batchelor, H.K., Bennett, J., Coupe, A., Ernest, T.B., Orlu, M., Tuleu, C., 2018. Acceptability of placebo multiparticulate formulations in children and adults. Sci. Rep. 1–10. https://doi.org/10.1038/s41598-018-27446-6.

Matta, Z., Chambers IV, E., Garcia, J.M., Helverson, J.M.G., 2006. Sensory characteristics of beverages prepared with commercial thickeners used for dysphagia diets. J. Am. Diet. Assoc. 106, 1049–1054. https://doi.org/10.1016/j.jada.2006.04.022.

Mennella, J.A., Finkbeiner, S., Reed, D.R., 2012. The proof is in the pudding: children prefer lower fat but higher sugar than do mothers. Int. J. Obes. 36, 1285–1291. https://doi.org/10.1038/ijo.2012.51.

Motte, J., Pedespan, J.M., Sevestre, M., Chiron, C., 2005. Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old. Arch. Pediatr. 12, 1533–1539. https://doi.org/10.1016/j.arcped.2005.07.009.

Mueller, S., Llewellin, E.W., Mader, H.M., 2010. The rheology of suspensions of solid particles. Proc. R. Soc. 466, 1201–1228. https://doi.org/10.1007/BF01432034.

O’Leary, M., Hanson, B., Smith, C., 2010. Viscosity and non-Newtonian features of thickened fluids used for dysphagia therapy. J. Food Sci. 75, E330–E338. https://doi.org/10.1111/j.1750-3841.2010.01673.x.

Ong, J.J.X., Steele, C.M., Duizer, L.M., 2018. Sensory characteristics of liquids thickened with commercial thickeners to levels specified in the International Dysphagia Diet Standardization Initiative (IDDSI) framework. Food Hydrocoll. 79, 208–217. https://doi.org/10.1016/j.foodhyd.2017.12.035.

Pelletier, C.A., 1997. A comparison of consistency and taste of five commercial thickeners. Dysphagia 12, 74–78. https://doi.org/10.1007/PL00009522.

Popper, R., Rosenstock, W., Schraidt, M., Kroll, B.J., 2004. The effect of attribute questions on overall liking ratings. Food Qual. Prefer. 15, 853–858. https://doi.org/10.1016/j.foodqual.2003.12.004.

Prescott, J., Lee, S.M., Kim, K.O., 2011. Analytic approaches to evaluation modify hedonic responses. Food Qual. Prefer. 22, 391–393. https://doi.org/10.1016/j.foodqual.2011.01.007.

Ruiz, F., Vallet, T., Pensé-Lhéritier, A.-M., Aoussat, A., 2016. Standardized method to assess medicines’ acceptability: focus on paediatric population. J. Pharm. Pharmacol. https://doi.org/10.1111/jphp.12547.

Saha, D., Bhattacharya, S., 2010. Hydrocolloids as thickening and gelling agents in food: a critical review. J. Food Sci. Technol. 47, 587–597. https://doi.org/10.1007/s13197-010-0162-6.

Soares, T.J., Moraes, D.P., de Medeiros, G.C., Sassi, F.C., Zilberstein, B., de Andrade, C.R.F., 2015. Oral transit time: a critical review of the literature. Arq. Bras. Cir. Dig. 28, 144–147. https://doi.org/10.1590/S0102-67202015000200015.

Steele, C.M., Alsanei, W.A., Ayanikalath, S., Barbon, C.E.A., Chen, J., Cichero, J.A.Y., Coutts, K., Dantas, R.O., Duivestein, J., Giosa, L., Hanson, B., Lam, P., Lecko, C., Leigh, C., Nagy, A., Namasivayam, A.M., Nascimento, W.V., Odendaal, I., Smith, C.H., Wang, H., 2015. The influence of food texture and liquid consistency modification on swallowing physiology and function: a systematic review. Dysphagia 30, 2–26. https://doi.org/10.1007/s00455-014-9578-x.

Stokes, J.R., Boehm, M.W., Baier, S.K., 2013. Oral processing, texture and mouthfeel: from rheology to tribology and beyond. Curr. Opin. Colloid Interface Sci. 18, 349–359. https://doi.org/10.1016/j.cocis.2013.04.010.

Szczesniak, A.S., Farkas, E., 1962. Objective characterization of the mouthfeel of gum solutions. J. Food Sci. 27, 381–385. https://doi.org/10.1111/j.1365-2621.1962. tb00112.x.

Ternik, R., Liu, F., Bartlett, J.A., Khong, M., Cheng, D., Tan, T., Dixit, T., Wang, S., Galella, E.A., Gao, Z., Klein, S., 2017. Assessment of swallowability and palatability of oral dosage forms in children: report from an M-CERSI pediatric formulation workshop. Int. J. Pharm. https://doi.org/10.1016/j.ijpharm.2017.08.088.

Verrotti, A., Nanni, G., Agostinelli, S., Alleva, E.T., Aloisi, P., Franzoni, E., Spalice, A., Chiarelli, F., Coppola, G., 2012. Effects of the abrupt switch from solution to modified-release granule formulation of valproate. Acta Neurol. Scand. 125, 14–18. https://doi.org/10.1111/j.1600-0404.2011.01568.x.

Walsh, J., Ranmal, S.R., Ernest, T.B., Liu, F., 2018. Patient acceptability, safety and access: a balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations. Int. J. Pharm. 536, 547–562. https://doi.org/10.1016/j.ijpharm.2017.07.017.

Yoshida, M., Hazekawa, M., Haraguchi, T., Uchida, T., 2011. Influence of swallowing Aids on the adsorption and palatability of Kremezin®. Chem. Pharm. Bull. (Tokyo) 59, 434–437. https://doi.org/10.1248/cpb.59.434.

Zlotkin, S., Antwi, K.Y., Schauer, C., Yeung, G., 2003. Use of microencapsulated iron(II) fumarate sprinkles to prevent recurrence of anaemia in infants and young children at high risk. Bull. World Health Organ. 81, 108–115. https://doi.org/10.1590/S0042-96862003000200007.

Multilayered pharmaceutically active compound-small

Introduction to Multilayered Pharmaceutically Active Compound Technology

Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form represent an innovative approach to oral drug delivery. This technology combines the benefits of coated pellets with the convenience of liquid administration. Effervescent tablets are solid dosage forms that release carbon dioxide when they dissolve in water. This reaction results from the interaction between an acid source, such as citric acid, and a carbonate or bicarbonate salt. Patients consume the resulting solution or suspension immediately after preparation. Consequently, effervescent tablets improve ease of administration and often enhance patient compliance.

Pellets play an increasingly important role in modern effervescent tablet formulations. Unlike conventional powder blends, pellets can carry individual functional coatings that protect active pharmaceutical ingredients (APIs) from degradation. In addition, pellets can separate incompatible ingredients within the same dosage form. They also improve taste masking and enable modified-release properties. As a result, formulators can develop more stable and effective products. Furthermore, pellet-containing effervescent tablets often reduce gastrointestinal irritation and improve dose uniformity. These advantages benefit both the final pharmaceutical product and the patient.

Multilayered pharmaceutically active compound-large

Multilayered pharmaceutically active compound-large

Summary of EP3117824A1

The European patent EP3117824A1 describes a drug delivery platform based on multilayered pharmaceutically active compound-releasing microparticles suspended in a liquid dosage form. The invention addresses a major challenge in pharmaceutical formulation. Many controlled-release and enteric-coated particles lose functionality when they remain in contact with water for extended periods. Therefore, maintaining stability during storage becomes difficult.

The patented technology uses microparticles that contain an API-loaded core surrounded by multiple functional coating layers. A controlled-release or enteric coating forms the intermediate layer. An additional outer protective layer surrounds this coating. The inventors designed this outer layer from a combination of hydrophilic and hydrophobic materials. Consequently, the layer protects the underlying release-controlling membrane from premature exposure to the liquid environment.

During storage, the protective coating minimizes drug leakage and preserves the integrity of the controlled-release system. As a result, the microparticles maintain their desired release characteristics for extended periods. Once the patient administers the formulation, the outer coating dissolves rapidly in the stomach. Subsequently, the underlying controlled-release coating resumes its intended function. This mechanism allows the formulation to deliver the API at a predefined location or rate within the gastrointestinal tract.

The invention offers particular advantages for drugs that require modified release, intestinal targeting, or protection from acidic gastric conditions. In addition, the technology supports the development of patient-friendly liquid formulations. This feature benefits pediatric, geriatric, and dysphagic patients who often struggle to swallow tablets or capsules. Overall, the patent combines the flexibility of pellet-based drug delivery with improved stability in aqueous dosage forms. Therefore, it represents an important advancement in oral pharmaceutical technology.

Impact of MCC spheres in this Patent

In EP3117824A1, CELLETS® or similar spherical starter cores serve as the fundamental substrate for producing the multilayered pharmaceutically active compound-releasing microparticles. These inert pellet cores, commonly composed of microcrystalline cellulose, provide a highly uniform and mechanically stable surface onto which drug-containing layers and subsequent functional coatings can be applied with high precision.

Their excellent sphericity promotes uniform coating thickness, which is critical for achieving reproducible controlled-release performance and minimizing variability between pellets. Furthermore, Cellets enable high drug loading while maintaining robust processing characteristics during fluid-bed coating operations.

Pellet size also plays an important role in the final product performance. Smaller pellets, typically in the range of 100–500 µm (such as CELLETS® 100, 200, 350), offer a larger surface area and can provide faster or more uniform drug release, whereas larger pellets, often between 500–1500 µm (such as CELLETS® 500, 700, 1000), facilitate the application of multiple coating layers and may support more sophisticated release profiles.

In addition, smaller pellets generally improve content uniformity and patient acceptability, especially in liquid and effervescent dosage forms, because they create a smoother mouthfeel and more homogeneous suspension. Therefore, selecting the appropriate Cellet size represents a key formulation parameter that influences coating efficiency, drug release kinetics, stability, and overall patient experience.

Acetylsalicylic Acid, Paracetamol, and Ascorbic Acid in Pellet-Based Effervescent Formulations

Although EP3117824A1 does not specifically focus on acetylsalicylic acid, paracetamol, or ascorbic acid, the technology applies well to these APIs. Acetylsalicylic acid, commonly known as aspirin, belongs to the nonsteroidal anti-inflammatory drug (NSAID) class. It treats pain, fever, inflammation, and cardiovascular disorders. Depending on the classification source and physiological conditions, aspirin generally falls within BCS Class I or Class III. Because aspirin can irritate the gastric mucosa, pellet-based controlled-release systems may improve gastrointestinal tolerability.

Paracetamol is an analgesic and antipyretic agent that treats pain and fever. It is generally classified as a BCS Class I compound due to its high solubility and permeability. Furthermore, pellet technology can improve taste masking and provide modified-release options. These properties make paracetamol formulations more suitable for pediatric and elderly patients.

Ascorbic acid, also known as vitamin C, functions as a water-soluble vitamin and antioxidant. Healthcare professionals use it to prevent and treat vitamin C deficiency. It exhibits high aqueous solubility and frequently appears in effervescent products. Moreover, pelletization can improve formulation stability by separating ascorbic acid from reactive ingredients. This approach may reduce degradation during storage and improve product quality.

Conclusion and Outlook

Multilayered pharmaceutically active compound technology offers a sophisticated solution for modern oral drug delivery. It combines coated pellet systems with liquid dosage forms while maintaining controlled-release functionality. Moreover, the technology supports improved stability, enhanced patient convenience, and flexible formulation design. When formulators incorporate pellets into effervescent tablets, they can protect sensitive APIs, reduce gastrointestinal side effects, and optimize therapeutic performance. As pharmaceutical research advances, multilayered pharmaceutically active compound systems will likely support more complex formulations and personalized treatment strategies. Consequently, this technology may become an increasingly important platform for next-generation oral medicines.

Patent Summary

  • Name of Patent: Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
  • Patent Number: EP3117824A1
  • Year of Patent: 2015
  • Patent Holders: Federica Ronchi, Jonathan Goole, Karim Amighi, Georges Guillaume, Vincent Stephenne
  • Affiliation: Be Pharbel Manufacturing
MCC pellets under rheological investigation-thumbnail

MCC pellets under rheological investigation

MCC pellets under rheological investigation are ideal model spheres for studying powder behavior. In this study, we revisit the work of V. Mohylyuk and R. Dattani to analyze the effect of pellet size on powder properties. Understanding how pellet size influences flow and handling is essential for optimizing powder performance. Moreover, investigating size variations helps improve material processing and formulation strategies. By focusing on these aspects, researchers can better predict and control the behavior of MCC spheres in different applications.

Rheological behavior has a deep impact

The rheological behavior of powders greatly affects pharmaceutical formulations and processing steps. In particular, when studying MCC pellets under rheological investigation, powder rheology becomes a key area of focus. Typically, powders behave as solids under static conditions; however, they can fluidize under certain circumstances. Consequently, fluidization is widely used in pharmaceutical processes because it enables controlled and uniform coating or layering of starter beads with drugs and functional excipients. Moreover, while fluid behavior in liquids depends on inter- and intra-molecular interactions, network bonds, and temperature, powder fluidization primarily relies on micro-particular properties such as particle size, surface characteristics, and flowability. In addition, the exact gas speed and volume required for powder fluidization must be carefully adjusted for each system. Therefore, a thorough analysis of the powder is essential to achieve precise control and optimal performance.

Materials: MCC pellets

CELLETS®

In this study, CELLETS® are used for the investigation. These pellets consist of Microcrystalline Cellulose, featuring a smooth surface, high sphericity, and minimal friability. Due to these properties, CELLETS® are popular as starter beads in pharmaceutical formulations and are ideal model spheres for rheological studies. Four types—CELLETS® 90, CELLETS® 100, CELLETS® 200, and CELLETS® 350—were examined, with size distributions ranging from 90 µm to 500 µm. The D50 values for these types vary between 94 µm and 424 µm. The specific size distribution of each CELLETS® type is summarized in Table 1.

Type Particle size distribution (≥ 85 %)
CELLETS® 90 60-100 µm
(250/150)
CELLETS® 100 100-200 µm
(150/80)
CELLETS® 200 200-355 µm
(80/50)
CELLETS® 350 350-500 µm
(50/35)

Table 1: Particle size distribution of selected MCC spheres.

 

MCC pellets under rheological investigation

Characterization Methods for MCC Pellets Under Rheological Investigation

First, we measured the particle size distribution of MCC pellets under rheological investigation using optical digital microscopy (Keyence VHX 600). This approach provides precise and reliable data on pellet dimensions, which is essential for understanding their flow and handling properties.

Next, we applied standard pharmacopoeia methods to determine bulk and tapped density, as well as flow rate using a gravitational funnel. In addition, we analyzed the dynamic angle of repose and dynamic cohesivity index with a rotating drum tester (GranuDrum). Furthermore, we used a powder rheometer (FT4 Powder Rheometer) to evaluate basic flowability energy, specific energy, aerated energy, permeability, and compressibility. Altogether, these measurements give a comprehensive understanding of MCC pellets under rheological investigation and offer detailed insights into their performance in pharmaceutical applications.

Results of the rheological investigations

Figure 1 presents the particle size distribution of MCC pellets under rheological investigation, as measured with an optical digital microscope.

Mohylyuk 2022 MCC pellets under rheological investigation image 1

With increasing particle size the apparent specific surface area (fig. 2) decreases obviously. Hence, a decrease in pellet size, allow an expectation in increase in mechanical interlocking.

Mohylyuk 2022 MCC pellets under rheological investigation image 2
specific surface area

With increasing particle size, the bulk and tapped density of CELLETS® increases; however, the densification kinetics remained approximately the same for all pellet sizes (Fig. 3). Moreover, a few periodic oscillations significantly influenced the density of the pellets, highlighting subtle variations in their behavior.

density

With increasing particle size the compressibility decreases (fig. 4). The applied force was identical for all pellets sizes. Worsening packing efficiency.

Mohylyuk 2022 MCC pellets under rheological investigation image 4 compressibility

With increasing particle size the permeability increases while applying the same force for all pellet types. (fig. 5). increase in voids between particles.

permeability

The gravitational funnel method suggests an absence of correlation between the mass flow rate and pellet size or specific surface area (fig. 6).

mass flow rate

Analyzing the dynamic angle of repose

We analyzed the dynamic angle of repose to evaluate the powder flow of MCC pellets under rheological investigation. All pellet sizes showed similar behavior: as the rotation speed increased, the angle of repose rose almost linearly. The measurements for all pellet types formed a funnel shape within the range of analytic errors (Fig. 7). These results clearly characterize the dynamic flow ability of the powders.

Mohylyuk 2022 MCC pellets under rheological investigation image 7 angle

With increasing particle size the specific energy decreases (fig. 8). The level of interlocking and friction between powder particles decreased, the flowability increased.

Image 8 specific energy

With increasing particle size the basic flowability energy decreases (fig. 9). the flowability in a constrained environment increased.

basic flowability

The aerated energy rises as air velocity decreases (Fig. 10). This parameter helps determine the minimum fluidization velocity, as increasing air velocity alters interparticle interactions.

aerated energy

The aerated energy increased with increasing pellet size (fig. 11). dependent on particle mass and inter-particle interactions (friction).

Mohylyuk 2022 MCC pellets under rheological investigation image 11 aerated energy size

with increasing pellet size, the cohesive index decreases (fig. 12). an indicator of the sum of inter-particle interaction forces.

12-cohesive index

Summary

Overall, researchers have now characterized MCC pellets under rheological investigation more comprehensively than ever before, providing new insights into their flow behavior and material properties. Powder rheology methods successfully revealed the bulk powder behavior, flow properties, and inter-particular interactions as a function of pellet size. CELLETS® served as robust model spheres made of Microcrystalline Cellulose, making them ideal for these detailed investigations. This study highlights the importance of pellet size in predicting and optimizing powder performance in pharmaceutical formulations.

References

[1] V. Mohylyuk and R. Dattani, “Assessment of the effect of microcrystalline cellulose (MCC) spheres size on the flow via powder rheology”, Conference: The FORGE: Hybrid Conference on Particle Characterisation (March 2022), doi:10.13140/RG.2.2.14935.75688

 

Cellets list of publication

Research Advances in MCC Pellet Technology and Applications

Scientific literature on MCC pellets highlights the growing importance of CELLETS® in pharmaceutical and scientific research. These microcrystalline cellulose spheres play a key role in developing reliable multiparticulate drug delivery systems. Researchers have investigated improved rivaroxaban dissolution, efficient film coating kinetics, and their use in orally disintegrating films. In addition, studies focus on colon-targeted vitamin B₂ release and fluidized-bed coating performance. Moreover, academic theses explore uniform hot-melt coating techniques and detailed modeling of tablet disintegration. As a result, MCC pellets continue to prove their versatility across many dosage forms. Consequently, this expanding body of literature reinforces the value of CELLETS® in advancing modern drug delivery technologies.

Selected Scientific literature on MCC pellets

Please, find scientific literature on MCC pellets (CELLETS®), MCC spheres. This list is constantly updated and does not claim to be complete. If you are author, scientist or R&D specialist, please submit your present publication to us for improving the visibility.

List – Publications with MCC spheres, 2026

Research article
High-Potency Pellet Microdosing Technology: A smart and easy way for production of low-dose active-ingredient capsules.
Tech4Pharma, 16(2), 2026, 58
A. Grave, E. Sternberger-Rützel

Research article
Formulation and Functional Characterization of a Novel Co-Processed Excipient for Direct Compression: Evaluation by the SeDeM Expert System
Preprint; doi: 10.20944/preprints202604.0109.v1
A. Ciurba, P. Antonoaea, E.-M. Rédai, A. Pintea, C. Pintea, A.-A. Cojocariu, M. Bîrsan, M.-F. Mihalcea, R.-A. Vlad

Research article
Challenges in the Oral Administration of Gastro-Resistant Formulations: The Role of Vehicles and Bottled Waters
Pharmaceutics 2026, 18(4), 453; doi: 10.3390/pharmaceutics18040453
A.K. Demeter, D. Farkas, M. Király, Á.T. Barna, K. Ludányi, I. Antal, N. Kállai-Szabó

Poster
Investigation of Pellet Agglomeration in Fluidised Bed Coating Processes: Influences of Size, Material, and Dispersion
Poster contribution, 2026
R. Jurek; M. Lachmann; E. Kempnich; K. Köhler

Research article
Pharmaceutical development of composition of effervescent tablets with acetylsalicylic acid, paracetamol, and ascorbic acid
Pharmaceutical Science Advances 4 (2026) 100123. doi: 10.1016/j.pscia.2026.100123
O. Panysheva

Research article
Enhancement of the Solubility and Dissolution Profile of Rivaroxaban by the Antisolvent Precipitation Technique: A Promising Approach
Polymers 2026, 18(9), 1134; doi: 10.3390/polym18091134
C. M. Benga, E. A. Ozon, A. M. Musuc, V. Anuța, I. Sârbu, V.-A. Surdu, F. Teodorescu, A. Rusu, L. Popa, M. V. Ghica, A. Chandak, C. E. D. Pîrvu

Research article
Modelling of Rheological Properties of Pharmaceutical Powder Mixtures for Direct Compression: A Statistical Approach
PharmSciTech 27, 121 (2026). doi: https://doi.org/10.1208/s12249-026-03359-w
P. Komínová, M. Gajdošová, D. Smrčka, P. Zámostný

Book
Pediatric Formulations – Micropellets: A Modern Multiparticulate Technology Platform for Pediatric Medicines | Springer Nature Link
Springer Cham (17 February 2026), ISBN 978-3-031-77239-9
H. Batchelor, K. Rose (Editors)

Book
GLATT-Wirbelschichttechnologie zum Coating von Pulvern, Pellets und Mikropellets
Springer-Verlag GmbH (02 January 2026), ISBN 978-3-662-71411-9 (print), 978-3-662-71412-6 (online); doi: 10.1007/978-3-662-71412-6_4
Annette Grave & Norbert Pöllinger

List – Publications with MCC spheres, 2025

Research article
Sustainable nanoarchitectonics of cellulose-derived spherical activated carbon for efficient uremic toxin removal in pharmaceutical applications
Materials & Design 259 (2025) 114892. doi: 10.1016/j.matdes.2025.114892
K. Shin, S.-B. Kim, Y.-H. Kim, D.-D. Kim, S.-Y. Lee, S.-J. Park

Research article
The Development and Characterization of Layered Pellets Containing a Combination of Amorphized Amlodipine Besylate and Hydrochlorothiazide Using a High-Shear Granulator
Pharmaceuticals 2025, 18(10), 1496. doi: 10.3390/ph18101496
A. A. K. Mahmoud, K. Ludasi, D. G. Dobó, D. Sebők, Á. Kukovecz, V. Hornok, K. Sajdik, T. Szabó, T. Sovány, G. Regdon, K. Kristó

Research article
Ultrasound Imaging of Artificial Tongues During Compression and Shearing of Food Gels on a Biomimetic Testing Bench
Journal of Texture Studies (2025) 56:e70030. doi: 10.1111/jtxs.70030
M. Glumac, J.-L. Gennisson, V. Mathieu

Research article
In vitro validation of colon delivery of vitamin B2 through a food grade multi-unit particle system
International Journal of Pharmaceutics (2025), 675, 125546. doi: 10.1016/j.ijpharm.2025.125546
M. Wolfgang, J. Poms, V. Herndler, I. Huegel, T. Kipping, M. Spoerk, J.G. Khinast

List – Publications with MCC spheres, 2024

Research article
In vitro validation of colon delivery of vitamin B2 through a food grade multi-unit particle system
Wageningen Academic (2024), eISSN: 1876-2891; doi:10.1163/18762891-bja00045
R.E. Steinert, W. Sybesma, R. Duss, A. Rehman, M. Watson, T.C. van den Ende, E. Funda

Research article
Homogeneity and mechanical properties of orodispersible films loaded with pellets
Eur. J. Pharm. Biopharm. 2024, 114537; doi:10.1016/j.ejpb.2024.114537
K. Centkowska, M. Szadkowska, M. Basztura, M. Sznitowska

Patent
Extended-release compositions comprising atomoxetine
A1

Patent
Extended release compositions comprising pyridostigmine
A1

Research article
Influence of Polymer Film Thickness on Drug Release from Fluidized Bed Coated Pellets and Intended Process and Product Control
Pharmaceutics 2024, 16(10), 1307; https://doi.org/10.3390/pharmaceutics16101307
M. Langner, F. Priese, and B. Wolf

Thesis
Characterization of dense granular flows using a continuous chute flow rheometer
Purdue University, School of Materials Engineering, West Lafayette, Indiana, posted on 2024-07-20, 03:12
Kayli Lynn Henry

Research article
The Increase in the Plasticity of Microcrystalline Cellulose Spheres’ When Loaded with a Plasticizer
Pharmaceutics (2024), 16(7), 945; doi: 10.3390/pharmaceutics16070945
A. Paulausks, T. Kolisnyk, V. Mohylyuk

Research article
The development of an innovative method to improve the dissolution performance of rivaroxaban
Heliyon 10(12), 2024, e33162; doi: 10.1016/j.heliyon.2024.e33162
E.A. Ozon, E. Mati, O. Karampelas, V. Anuta, I. Sarbu, A.M. Musuc, R.-A. Mitran, D.C. Culita, I. Atkinson, M. Anastasescu, D. Lupuliasa, M.A. Mitu

Thesis
Uniform and homogenous hot-melt coating in a Wurster fluidized bed
TUM School of Life Sciences der Technischen Universität München, 2024
B. M. Wörthmann

Thesis
Modelling the disintegration of pharmaceutical tablets: integrating a single particle swelling model with the discrete element method
University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, CMAC National Facility, 2024, Thesis identifier T16863
M. Soundaranathan

List – Publications with MCC spheres, 2023

Research article
Paediatric solid oral dosage forms for combination products: Improving in vitro swallowability of minitablets using binary mixtures with pellets
European Journal of Pharmaceutical Sciences (2023), 187, 106471; doi:10.1016/j.ejps.2023.106471
A. Avila-Sierra, A. Lavoisier, C. Timpe, P. Kuehl, L. Wagner, C. Tournier, M. Ramaioli

Research article
Continuous Manufacturing of Cocrystals Using 3D-Printed Microfluidic Chips Coupled with Spray Coating
Pharmaceuticals (2023), 16(8), 1064; doi:10.3390/ph16081064
A. Kara, D. Kumar 2, A.M. Healy, A. Lalatsa, and D.R. Serrano

Research article
High-Speed Tableting of High Drug-Loaded Tablets Prepared from Fluid-Bed Granulated Isoniazid
Pharmaceuticals (2023), 15(4), 1236; doi:10.3390/pharmaceutics15041236
V. Mohylyuk, and D. Bandere

Research article
The Effect of Design and Size of the Fluid‑Bed Equipment on the Particle Size‑Dependent Trend of Particle Coating Thickness and Drug Prolonged‑Release Profile
AAPS PharmSciTech (2023) 24, 93. doi:10.1208/s12249-023-02540-9
T. Brezovar, G. Hudovornik, M. Perpar, M. Luštrik, R. Dreu

Research article
Amorphous Solid Dispersions Layered onto Pellets—An Alternative to Spray Drying?
Pharmaceutics (2023) 15(3), 764. doi:10.3390/pharmaceutics15030764
M. Neuwirth, S.K. Kappes, M.U. Hartig, K.G. Wagner

Research article
Optimization of Fluidized-Bed Process Parameters for Coating Uniformity and Nutrient-Release Characteristics of Controlled-Release Urea Produced by Modified Lignocellulosic Coating Material
Agronomy (2023) 13(3), 725. doi:10.3390/agronomy13030725
A.M. Ali, B. Azeem, A.M. Alghamdi, K. Shahzad, A. Ahmad Al-Zahrani, M. Imtiaz Rashid, A. Binti Mahpudz, A. Jamil

Research article
Hydrodynamic behaviour of CELLETS® (Ph.Eur./USP) in a spouted bed using image processing method
Particuology (2023), 76, 101-112, doi:10.1016/j.partic.2022.07.009
J. Vanamu, A. Sahoo

Thesis
Oral delivery of microbiome-modulating synbiotics derived from kefir via alginate encapsulation systems
School of Materials Science and Engineering (2023); doi: 10.32657/10356/164624
L.L. Tan

List – Publications with MCC spheres, 2022

Research article
Review on Starter Pellets: Inert and Functional Cores
Pharmaceutics 2022, 14(6), 1299; doi: 10.3390/pharmaceutics14061299
N. Kállai-Szabó, M. Lengyel, D. Farkas, Á. T. Barna, C. Fleck, B. Basa, and I. Antal

Research article
Product-Property Guided Scale-Up of a Fluidized Bed Spray Granulation Process Using the CFD-DEM Method
Processes (2022) 10(7), 1291. doi:10.3390/pr10071291
P. Kieckhefen, S. Pietsch-Braune, S. Heinrich

Research article
Influence of In Situ Calcium Pectinate Coating on Metoprolol Tartrate Pellets for Controlled Release and Colon-Specific Drug Delivery
Pharmaceutics (2022) 14(5), 1061. doi: 10.3390/pharmaceutics14051061
P. Wanasawas, A. Mitrevej, N. Sinchaipanid

Research article
Delamination and wetting behavior of natural hot-melt coating materials
Powder Technology (2022) 404, 117443. doi: 10.1016/j.powtec.2022.117443
B.M. Woerthmann, L. Totzauer, H. Briesen

Research article
A systematic approach for assessing the suitability of enteral feeding tubes for the administration of controlled-release pellet formulations
International Journal of Pharmaceutics (2022) 612, 121286. doi: 10.1016/j.ijpharm.2021.121286
F. Karkossa, N. Lehmann, S. Klein

Research article
Spray-freeze-dried lyospheres: Solid content and the impact on flowability and mechanical stability
Powder Technology (2022) 411, 117905. doi:10.1016/j.powtec.2022.117905
A. Rautenberg, A. Lamprecht

Conference proceedings
Assessment of the effect of microcrystalline cellulose (MCC) spheres size on the flow via powder rheology
The FORGE, 2022 – pure.qub.ac.uk; doi: 10.13140/RG.2.2.14935.75688
V. Mohylyuk, R. Dattani

Research article
Solventless amorphization and pelletization using a high shear granulator. Part II; Preparation of co-amorphous mixture-layered pellets using indomethacin and arginine
European Journal of Pharmaceutics and Biopharmaceutics (2022) 181, 183-194. doi: 10.1016/j.ejpb.2022.11.011
K. Kondo, T. Rades

Research article
Solventless amorphization and pelletization using a high shear granulator. Part I; feasibility study using indomethacin
European Journal of Pharmaceutics and Biopharmaceutics (2022) 181, 147-158. doi: 10.1016/j.ejpb.2022.11.010
K. Kondo, T. Rades

Research article
Application of different models to evaluate the key factors of fluidized bed layering granulation and their influence on granule characteristics
Powder Technology (2022), 408:117737. doi: 10.1016/j.powtec.2022.117737
R. Maharjan, S. H. Jeong

Research article
Evaluation of gravitational consolidation of binary powder mixtures by modified Heckel equation
Powder Technology (2022), 408:117729. doi: 10.1016/j.powtec.2022.117729
P. Svačinová, O. Macho, Ž. Jarolímová, M. Kuentz, Ľ. Gabrišová and Z. Šklubalová

Research article
Integrated Purification and Formulation of an Active Pharmaceutical Ingredient via Agitated Bed Crystallization and Fluidized Bed Processing
Pharmaceutics (2022), 14(5)1058. doi: 10.3390/pharmaceutics14051058
M. W. Stocker, M. J. Harding, V. Todaro, A. M. Healy and S. Ferguson

List – Publications with MCC spheres, 2021

Research article
Correlating Granule Surface Structure Morphology and Process Conditions in Fluidized Bed Layering Spray Granulation
KONA Powder and Particle Journal (2021), DOI:10.14356/kona.2022016
M. Orth, P. Kieckhefen, S. Pietsch and S. Heinrich

Research article
Relative bioavailability enhancement of simvastatin via dry emulsion systems: comparison of spray drying and fluid bed layering technology
Eur J Pharm Biopharm (2021), S0939-6411(21)00353-2. doi: 10.1016/j.ejpb.2021.12.004
M. Pohlen, J. Aguiar Zdovc, J. Trontelj, J. Mravljak, M. G. Matjaž, I. Grabnar, T. Snoj and R. Dreu

Research article
A novel method for assessing the coating uniformity of hot-melt coated particles using micro-computed tomography
Powder Technology, Volume 378, Part A, 22 January 2021, Pages 51-59
B.M. Woerthmann, J.A. Lindner, T. Kovacevic, P. Pergam, F. Schmid, H. Briesen

List – Publications with MCC spheres, 2020

Research article
Fixed-bed-column studies for methylene blue removal by cellulose CELLETS
Environmental Engineering and Management Journal 19 (2020), 2, 269-279
Iulia Nica, Gabriela Biliuta, Carmen Zaharia, Lacramioara Rusu, Sergiu Coseri, Daniela Suteu

Research article
Material specific drying kinetics in fluidized bed drying under mechanical vibration using the reaction engineering approach
Advanced Powder Technology, Volume 31, Issue 12, December 2020, Pages 4699-4713
Soeren E. Lehmann, Tobias Oesau, Alfred Jongsma, Fredrik Innings, Stefan Heinrich

Research article
Simulation of pellet coating in Wurster coaters
International Journal of Pharmaceutics, Volume 590, 30 November 2020, 119931
Hamid Reza Norouzi

Research article
Quantification of swelling characteristics of pharmaceutical particles
International Journal of Pharmaceutics, Volume 590, 30 November 2020, 119903
Mithushan Soundaranathan, Pattavet Vivattanaseth, Erin Walsh, Kendal Pitt, Blair Johnston, Daniel Markl

Short communication
Introduction of the energy to break an avalanche as a promising parameter for powder flowability prediction
Powder Technology, Volume 375, 20 September 2020, Pages 33-41
Žofie Trpělková, Hana Hurychová, Martin Kuentz, Barbora Vraníková, Zdenka Šklubalová

Research article
Easy to Swallow “Instant” Jelly Formulations for Sustained Release Gliclazide Delivery
Journal of Pharmaceutical Sciences, Volume 109, Issue 8, August 2020, Pages 2474-2484
Simmi Patel, Nathan Scott, Kavil Patel, Valentyn Mohylyuk, William J. McAuley, Fang Liu

Research article
Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles
International Journal of Pharmaceutics, Volume 585, 30 July 2020, 119562
Nathan Scott, Kavil Patel, Tariro Sithole, Konstantina Xenofontos, Valentyn Mohylyuk, Fang Liu

Research article
Measuring segregation characteristics of industrially relevant granular mixtures: Part II – Experimental application and validation
Powder Technology, Volume 368, 15 May 2020, Pages 278-285
Alexander M. Fry, Vidya Vidyapati, John P. Hecht, Paul B. Umbanhowar, Julio M. Ottinoa, Richard M. Lueptow

Research article
Non-uniform drug distribution matrix system (NUDDMat) for zero-order release of drugs with different solubility
International Journal of Pharmaceutics, Volume 581, 15 May 2020, 119217
Matteo Cerea, Anastasia Foppoli, Luca Palugan, Alic Melocchi, Lucia Zema, Alessandra Maroni, Andrea Gazzaniga

Research article
Effects of humidity on cellulose pellets loaded with potassium titanium oxide oxalate for detection of hydrogen peroxide vapor in powders
Powder Technology, Volume 366, 15 April 2020, Pages 348-357
Maria H. Kastvig, Cosima Hirschberg, Frans W.J. Van Den Berg, Jukka Rantanen, Mogens L. Andersen

Research article
In-line particle size measurement and process influences on rotary fluidized bed agglomeration
Powder Technology, Volume 364, 15 March 2020, Pages 673-679
Marcel Langner, Ivonne Kitzmann, Anna-Lena Ruppert, Inken Wittich, Bertram Wolf

Research article
Recent advance in delivery system and tissue engineering applications of chondroitin sulfate
Carbohydrate Polymers, Volume 230, 15 February 2020, 115650
Jun Yang, Mingyue Shen, Huiliang Wen, Yu Luo, Rong Huang, Liyuan Rong, Jianhua Xie

Research article
Fixed-bed-column studies for Methylene blue removal by Cellulose CELLETS
Environmental Engineering and Management Journal, Volume 19 (2), March 2020, 269-279
Iulia Nica, Gabriela Biliuta, Carmen Zaharia, Lacramioara Rusu, Sergiu Coseri, Daniela Suteu

Research article
Optimization and tracking of coating processes of pellets with polyvinylpyrrolidone solutions in an acoustic levitator
Powder Technology, Volume 360, 15 January 2020, Pages 1126-1133
Doris L. Wong, Anna-Lena Wirsching, Kai Betz, Andreas Reinbeck, Hans-Ulrich Moritz, Werner Pauer

List – Publications with MCC spheres, 2019

Research article
A regenerable microporous adsorbent based on microcrystalline cellulose for organic pollutants adsorption
Desalination and Water Treatment Volume 146, April 2019, Pages 176-187
Daniela Suteu, Gabriela Biliuta, Lacramioara Rusu, Sergiu Coseri, Christophe Vial, Iulia Nica (Nebunu)

Research article
Measurement of hydrogen peroxide vapor in powders with potassium titanium oxide oxalate loaded cellulose pellets as probes
AAPS PharmSciTech, Volume 21(1):3, 11 Nov 2019
Maria H. Kastvig, Johan P. Bøtker, Ge Ge, Mogens L. Andersen

Research article
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production of Oral Sustained-Release Liquid Medicines for Patients with Swallowing Difficulties
AAPS PharmSciTech, Volume 21(1):3, 11 Nov 2019
Valentyn Mohylyuk, Kavil Patel, Nathan Scott, Craig Richardson, Darragh Murnane, Fang Liu

Research article
Assessment of the effect of Cellets’ particle size on the flow in a Wurster fluid-bed coater via powder rheology
Journal of Drug Delivery Science and Technology, 54, December 2019, 101320; doi: 10.1016/j.jddst.2019.101320
Valentyn Mohylyuk, Ioanna Danai Styliari, Dmytryi Novykov, Reiss Pikett, Rajeev Dattani

Research article
Particle electrification in an apparatus with a draft tube operating in a fast circulating dilute spout-fluid bed regime
Particuology, Volume 42, February 2019, Pages 146-153
Wojciech Ludwig

Research article
Development and evaluation of budesonide-based modified-release liquid oral dosage forms
Journal of Drug Delivery Science and Technology, Volume 54, December 2019, 101273
Federica Ronchi, Antonio Sereno, Maxime Paide, Ismaël Hennia, Pierre Sacré, George Guillaume, Vincent Stéphenne, Jonathan Goole, Karim Amighi

Research article
Evaluation of in-line particle measurement with an SFT-probe as monitoring tool for process automation using a new time-based buffer approach
European Journal of Pharmaceutical Sciences, Volume 128, 1 February 2019, Pages 162-170
Theresa Reimers, Jochen Thies, Stefan Dietrich, Julian Quodbach, Miriam Pein-Hackelbusch

Research article
In vitro and sensory tests to design easy-to-swallow multi-particulate formulations
European Journal of Pharmaceutical Sciences, Volume 132, 30 April 2019, Pages 157-162
Marco Marconati, Felipe Lopez, Catherine Tuleu, Mine Orlu, Marco Ramaioli

Research article
Numerical study of the hydrodynamics of fluidized beds operated under sub-atmospheric pressure
Chemical Engineering Journal, Volume 372, 15 September 2019, Pages 1134-1153
Sayali Zarekar, Andreas Bück, Michael Jacob, Evangelos Tsotsas

Research article
Solidification of carvedilol loaded SMEDDS by swirling fluidized bed pellet coating
International Journal of Pharmaceutics, Volume 566, 20 July 2019, Pages 89-100
J. Mandić, M. Luštrik, F. Vrečer, M. Gašperlin, A. Zvonar Pobirk

Research article
Quantitative bin flow analysis of particle discharge using X-ray radiography
Powder Technology, Volume 344, 15 February 2019, Pages 693-705
Sanket Bacchuwar, Vidya Vidyapati, Ke-ming Quan, Chen-Luh Lin, Jan D. Miller

Research article
Adjustment of triple shellac coating for precise release of bioactive substances with different physico-chemical properties in the ileocolonic region
International Journal of Pharmaceutics, Volume 564, 10 June 2019, Pages 472-484>
Eva-Maria Theismann, Julia Katharina Keppler, Jörg-Rainer Knipp, Daniela Fangmann, Esther Appel, Stanislav N. Gorb, Georg H. Waetzig, Stefan Schreiber, Matthias Laudes, Karin Schwarz

Research article
The analysis of the influence of the normal restitution coefficient model on calculated particles velocities by means of Eulerian-Lagrangian approach
Powder Technology, Volume 344, 15 February 2019, Pages 140-151
Wojciech Ludwig, PaweƚPłuszka

Research article
Measurement of granule layer thickness in a spouted bed coating process via optical coherence tomography
Powder Technology, Volume 356, November 2019, Pages 139-147
Swantje Pietsch, Anna Peter, Patrick Wahl, Johannes Khinast, Stefan Heinrich

Research article
A novel method of quantifying the coating progress in a three-dimensional prismatic spouted bed
Particuology, Volume 42, February 2019, Pages 137-145
Swantje Pietsch, Finn Ole Poppinga, Stefan Heinrich, Michael Müller, Michael Schönherr, Frank Kleine Jäger

Research article
Development and evaluation of an omeprazole-based delayed-release liquid oral dosage form
International Journal of Pharmaceutics, Volume 567, 15 August 2019, 118416
Federica Ronchi, Antonio, Sereno, Maxime Paide, Pierre Sacré, George Guillaume, Vincent Stéphenne, Jonathan Goole, Karim Amighi

Research article
Influence of separation properties and processing strategies on product characteristics in continuous fluidized bed spray granulation
Powder Technology, Volume 342, 15 January 2019, Pages 572-584
Daniel Müller, Andreas Bück, Evangelos Tsotsas

List – Publications with MCC spheres, 2018

Short communication
Novel production method of tracer particles for residence time measurements in gas-solid processes
Powder Technology, Volume 338, October 2018, Pages 1-6
Swantje Pietsch, Paul Kieckhefen, Michael Müller, Michael Schönherr, Frank Kleine Jäger, Stefan Heinrich

Research article
The effect of administration media on palatability and ease of swallowing of multiparticulate formulations
International Journal of Pharmaceutics, Volume 551, Issues 1–2, 15 November 2018, Pages 67-75
Felipe L. Lopez, Terry B. Ernest, Mine Orlu, CatherineTuleu

Research article
Exploring a Modern Control Strategy for Wurster Coating
Pharmaceutical Technology, 2018, 43(8), 453
E. Godek, C. O’Callaghan, I. Jones, P. Patel

Research article
Compressibility and tablet forming ability of bimodal granule mixtures: Experiments and DEM simulations
International Journal of Pharmaceutics, Volume 540, Issues 1–2, 5 April 2018, Pages 120-131
Josefina Nordström, Göran Alderborn, Göran Frenning

Research article
Effects of pharmaceutical processes on the quality of ethylcellulose coated pellets: Quality by design approach
Powder Technology, Volume 339, November 2018, Pages 25-38
Prakash Thapa, Ritu Thapa, Du Hyung Choi, Seong Hoon Jeong

Research article
Euler-Lagrange model of particles circulation in a spout-fluid bed apparatus for dry coating
Powder Technology, Volume 328, 1 April 2018, Pages 375-388
Wojciech Ludwig, Paweł Płuszka

Research article
Inline acoustic monitoring to determine fluidized bed performance during pharmaceutical coating
International Journal of Pharmaceutics, Volume 549, Issues 1–2, 5 October 2018, Pages 293-298
Allan Carter, Lauren Briens

Research article
Sifting segregation of ideal blends in a two-hopper tester: Segregation profiles and segregation magnitudes
Powder Technology, Volume 331, 15 May 2018, Pages 60-67
Mariagrazia Marucci, Banien Al-Saaigh, Catherine Boissier, Marie Wahlgren, Håkan Wikström

Conference abstract
Multiple unit mini-tablets: Content uniformity issues
International Journal of Pharmaceutics, Volume 536, Issue 2, 5 February 2018, Pages 506-507
Anna Kira Adam, Jörg Breitkreutz

Research article
Influence of gas inflow modelling on CFD-DEM simulations of three-dimensional prismatic spouted beds
Powder Technology, Volume 329, 15 April 2018, Pages 167-180
Paul Kieckhefen, Swantje Pietsch, Moritz Höfert, Michael Schönherr, Stefan Heinrich, Frank Kleine Jäger

Research article
A redispersible dry emulsion system with simvastatin prepared via fluid bed layering as a means of dissolution enhancement of a lipophilic drug
International Journal of Pharmaceutics, Volume 549, Issues 1–2, 5 October 2018, Pages 325-334
Mitja Pohlen, Luka Pirker, Matevž Luštrik, Rok Dreu

Review article
Overview of PAT process analysers applicable in monitoring of film coating unit operations for manufacturing of solid oral dosage forms
European Journal of Pharmaceutical Sciences, Volume 111, 1 January 2018, Pages 278-292
Klemen Korasa, Franc Vrečer

Research article
On the properties and application of beeswax, carnauba wax and palm fat mixtures for hot melt coating in fluidized beds
Advanced Powder Technology, Volume 29, Issue 3, March 2018, Pages 781-788
M.G. Müller, J.A. Lindner, H. Briesen, K. Sommer, P. Foerst

Research article
Novel hydrophilic matrix system with non-uniform drug distribution for zero-order release kinetics
Journal of Controlled Release, Volume 287, 10 October 2018, Pages 247-256
Matteo Cerea, Alessandra Maroni, Luca Palugan, Marco Bellini, Anastasia Foppoli, Alice Melocchi, Lucia Zema, Andrea Gazzaniga

Research article
Role of plasticizer in membrane coated extended release oral drug delivery system
Journal of Drug Delivery Science and Technology, Volume 44, April 2018, Pages 231-243
Pinak Khatri, Dipen Desai, Namdev Shelke, Tamara Minko

Research article
Evaluation of pellet cycle times in a Wurster chamber using a photoluminescence method
Chemical Engineering Research and Design, Volume 132, April 2018, Pages 1170-1179
Domen Kitak, Rok Šibanc, Rok Dreu

Research article
Influence of perforated draft tube air intake on a pellet coating process
Powder Technology, Volume 330, 1 May 2018, Pages 114-124
Matevž Luštrik, Rok Dreu, Matjaž Perpar

Research article
Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating
European Journal of Pharmaceutics and Biopharmaceutics, Volume 124, March 2018, Pages 13-27
Dolores R. Serrano, David Walsh, Peter O’Connell, Naila A. Mugheirbi, Zelalem Ayenew Worku, Francisco Bolas-Fernandez, Carolina Galiana, Maria Auxiliadora Dea-Ayuela, Anne Marie Healy


Research article

Research article
Mechanics of Pharmaceutical Pellets—Constitutive Properties, Deformation, and Breakage Behavior
Journal of Pharmaceutical Sciences, Volume 107, Issue 2, February 2018, Pages 571-586
Alexander Russell, Rok Šibanc, Rok Dreu, Peter Müller

List – Publications with MCC spheres, 2017

Research article
Production of composite particles using an innovative continuous dry coating process derived from extrusion
Advanced Powder Technology, Volume 28, Issue 11, November 2017, Pages 2875-2885
Fanny Cavaillès, Romain Sescousse, Alain Chamayou, Laurence Galet

Research article
Determination of the release mechanism of Theophylline from pellets coated with Surelease®—A water dispersion of ethyl cellulose
International Journal of Pharmaceutics, Volume 528, Issues 1–2, 7 August 2017, Pages 345-353
Jurgita Kazlauske, Maria Margherita Cafaro, Diego Caccavo, Mariagrazia Marucci, Gaetano Lamberti, Anna Angela Barba, Anette Larsson

Research article
In-line monitoring of multi-layered film-coating on pellets using Raman spectroscopy by MCR and PLS analyses
European Journal of Pharmaceutics and Biopharmaceutics, Volume 114, May 2017, Pages 194-201
Jin Hisazumi, Peter Kleinebudde

Research article
Analysis of pellet coating uniformity using a computer scanner
International Journal of Pharmaceutics, Volume 533, Issue 2, 30 November 2017, Pages 377-382
Rok Šibanc, Matevž Luštrik, Rok Dreu

Research article
Modeling of particle velocities in an apparatus with a draft tube operating in a fast circulating dilute spout-fluid bed regime
Powder Technology, Volume 319, September 2017, Pages 332-345
Wojciech Ludwig, Daniel Zając

Research article
UV imaging of multiple unit pellet system (MUPS) tablets: A case study of acetylsalicylic acid stability
European Journal of Pharmaceutics and Biopharmaceutics, Volume 119, October 2017, Pages 447-453
Anna Novikova, Jens M. Carstensen, Thomas Rades, Claudia S. Leopold

Research article
Influence of Water on the Structure and Dielectric Properties of the Microcrystalline and Nano-Cellulose
Nanoscale Res Lett 12, 468 (2017); doi: 10.1186/s11671-017-2231-5
Kovalov, K.M., Alekseev, O.M., Lazarenko, M.M.

Research article
New hybrid CPU-GPU solver for CFD-DEM simulation of fluidized beds
Powder Technology, Volume 316, 1 July 2017, Pages 233-244
H.R. Norouzi, R. Zarghami, N. Mostoufi

Research article
A top coating strategy with highly bonding polymers to enable direct tableting of multiple unit pellet system (MUPS)
Powder Technology, Volume 305, January 2017, Pages 591-596
Frederick Osei-Yeboah, Yidan Lan, Changquan Calvin Sun

Research article
Synthesis and melt processing of cellulose esters for preparation of thermoforming materials and extended drug release tablets
Carbohydrate Polymers, Volume 177, 1 December 2017, Pages 105-115
Sanna Virtanen, Riku Talja, Sauli Vuoti

Research article
Downstream drug product processing of itraconazole nanosuspension: Factors influencing drug particle size and dissolution from nanosuspension-layered beads
International Journal of Pharmaceutics, Volume 524, Issues 1–2, 30 May 2017, Pages 443-453
Johannes Parmentier, En Hui Tan, Ariana Low, Jan Peter Möschwitzer

List – Publications with MCC spheres, 2016

Research article
In-line particle size measurement and agglomeration detection of pellet fluidized bed coating by Spatial Filter Velocimetry
Powder Technology, Volume 301, November 2016, Pages 261-267
Dimitri Wiegel, Günter Eckardt, Florian Priese, Bertram Wolf

Research article
Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers
European Journal of Pharmaceutical Sciences, Volume 92, 20 September 2016, Pages 156-162
Felipe L. Lopez, Alexandra Bowles, Mine Orlu Gul, David Clapham, Terry B. Ernest, Catherine Tuleu

Research article
Micropellet-loaded rods with dose-independent sustained release properties for individual dosing via the Solid Dosage Pen
International Journal of Pharmaceutics, Volume 499, Issues 1–2, 29 February 2016, Pages 271-279
Eva Julia Laukamp, Klaus Knop, Markus Thommes, Joerg Breitkreutz

Research article
Multivariate calibration of the degree of crystallinity in intact pellets by X-ray powder diffraction
International Journal of Pharmaceutics, Volume 502, Issues 1–2, 11 April 2016, Pages 107-116
Krisztina Nikowitz, Attila Domján, Klára Pintye-Hódi, Géza Regdon jr.

Research article
Towards improving quality of video-based vehicle counting method for traffic flow estimation
Signal Processing, Volume 120, March 2016, Pages 672-681
Yingjie Xia, Xingmin Shi, Guanghua Song, Qiaolei Geng, Yuncai Liu

Conference abstract
Multiple-unit orodispersible mini-tablets
International Journal of Pharmaceutics, Volume 511, Issue 2, 25 September 2016, Page 1128
Anna Kira Adam, Christian Zimmer, Stefan Rauscher, Jörg Breitkreutz

Research article
Asymmetric distribution in twin screw granulation
European Journal of Pharmaceutics and Biopharmaceutics, Volume 106, September 2016, Pages 50-58
Tim Chan Seem, Neil A. Rowson, Ian Gabbott, Marcelde Matas, Gavin K. Reynolds, AndyIngram

Research article
Measurement of particle concentration in a Wurster coater draft tube using light attenuation
Chemical Engineering Research and Design, Volume 110, June 2016, Pages 20-31
R. Šibanc, I. Žun, R. Dreu

List – Publications with MCC spheres, 2015

Research article
Two-dimensional particle shape analysis from chord measurements to increase accuracy of particle shape determination
Powder Technology, Volume 284, November 2015, Pages 25-31
D. Petrak, S. Dietrich, G. Eckardt, M. Köhler

Research article
Passive acoustic emission monitoring of pellet coat thickness in a fluidized bed
Powder Technology, Volume 286, December 2015, Pages 172-180
Taylor Sheahan, Lauren Briens

Research article
Tabletability Modulation Through Surface Engineering
Journal of Pharmaceutical Sciences, Volume 104, Issue 8, August 2015, Pages 2645-2648
Frederick Osei-Yeboah, Changquan Calvin Sun

Research article
Cellulose CELLETS as new type of adsorbent for the removal of dyes from aqueous media
Environmental Engineering and Management Journal, Volume 14, Issue 3, March 2015, Pages 525-532
Daniela Suteu, Gabriela Biliuta, Lacramioara Rusu, Sergiu Coseri, Gabriela Nacu

Research article
Formulation and process optimization of multiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane
International Journal of Pharmaceutics, Volume 480, Issues 1–2, 1 March 2015, Pages 15-26
Sheng-Feng Hung, Chien-Ming Hsieh, Ying-Chen Chen, Cheng-Mao Lin, Hsiu-O Ho, Ming-Thau Sheu

Research article
Dry Coating Characterization of Coverage by Image Analysis: Methodology
Procedia Engineering, Volume 102, 2015, Pages 81-88
Olivier Lecoq, Fredj Kaouach, Alain Chamayou

Research article
Passive acoustic emissions monitoring of the coating of pellets in a fluidized bed—A feasibility analysis
Powder Technology, Volume 283, October 2015, Pages 373-379
Taylor Sheahan, Lauren Briens

List – Publications with MCC spheres, 2014

Research article
A New Apparatus for Real‐Time Assessment of the Particle Size Distribution of Disintegrating Tablets
Journal of Pharmaceutical Sciences, Volume 103, Issue 11, November 2014, Pages 3657-3665
Julian Quodbach, Peter Kleinebudde

Research article
In-line spatial filtering velocimetry for particle size and film thickness determination in fluidized-bed pellet coating processes
European Journal of Pharmaceutics and Biopharmaceutics, Volume 88, Issue 3, November 2014, Pages 931-938
Friederike Folttmann, Klaus Knop, Peter Kleinebudde, Miriam Pein

Research article
On-line monitoring of fluid bed granulation by photometric imaging
European Journal of Pharmaceutics and Biopharmaceutics, Volume 88, Issue 3, November 2014, Pages 879-885
Ira Soppela, Osmo Antikainen, Niklas Sandler, Jouko Yliruusi

Research article
Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients
International Journal of Pharmaceutics
Volume 460, Issues 1–2, 2 January 2014, Pages 228-233

Anna Kluk, Malgorzata Sznitowska

Research article
In-line monitoring of pellet coating thickness growth by means of visual imaging
International Journal of Pharmaceutics, Volume 470, Issues 1–2, 15 August 2014, Pages 8-14
Nika Oman Kadunc, Rok Šibanc, Rok Dreu, Boštjan Likar, Dejan Tomaževič

Research article
Optical microscopy as a comparative analytical technique for single-particle dissolution studies
International Journal of Pharmaceutics, Volume 469, Issue 1, 20 July 2014, Pages 10-16
Sami Svanbäck, Henrik Ehlers, Jouko Yliruusi

Research article
Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs
European Journal of Pharmaceutics and Biopharmaceutics, Volume 87, Issue 1, May 2014, Pages 107-113
Lieselotte De Smet, Lien Saerens, Thomas De Beer, Robert Carleer, Peter Adriaensens, Jan Van Bocxlaer, Chris Vervaet, Jean PaulRemon

Research article
Global monitoring of fluidized-bed processes by means of microwave cavity resonances
Measurement, Volume 55, September 2014, Pages 520-535
Johan Nohlert, Livia Cerullo, Johan Winges, Thomas Rylander, Tomas McKelvey, Anders Holmgren, Lubomir Gradinarsky, Staffan Folestad, Mats Viberg, Anders Rasmuson

List – Publications with MCC spheres, 2013

Research article
Water-mediated solid-state transformation of a polymorphic drug during aqueous-based drug-layer coating of pellets
International Journal of Pharmaceutics, Volume 456, Issue 1, 1 November 2013, Pages 41-48
Andres Lust, Satu Lakio, Julia Vintsevits, Jekaterina Kozlova, Peep Veski, Jyrki Heinämäki, Karin Kogermann

Research article
Preparation and characterization of controlled-release doxazosin mesylate pellets using a simple drug layering-aquacoating technique
Journal of Pharmaceutical Investigation (2013), 43:333–342. doi: 10.1007/s40005-013-0077-0
H. A. Hazzah, M. A. EL-Massik, O. Y. Abdallah & H. Abdelkader

Research article
Development of high drug loaded pellets by Design of Experiment and population balance model calculation
Powder Technology, Volume 241, June 2013, Pages 149-157
Florian Priese, Bertram Wolf

Research article
Particle sizing measurements in pharmaceutical applications: Comparison of in-process methods versus off-line methods
European Journal of Pharmaceutics and Biopharmaceutics, Volume 85, Issue 3, Part B, November 2013, Pages 1006-1018
Ana F.T. Silva, Anneleen Burggraeve, Quenten Denon, Paul Van der Meeren, Niklas Sandler, Tom Van Den Kerkhof, Mario Hellings, Chris Vervaet, Jean Paul Remon, João Almeida Lopes, Thomas De Beer

Research article
Physical properties of pharmaceutical pellets
Chemical Engineering Science, Volume 86, 4 February 2013, Pages 50-60
Rok Šibanc, Teja Kitak, Biljana Govedarica, StankoSrčič Rok Dreu

Research article
Continuous pellet coating in a Wurster fluidized bed process
Chemical Engineering Science, Volume 86, 4 February 2013, Pages 87-98
N. Hampel, A. Bück, M. Peglow, E. Tsotsas

Research article
Study of the recrystallization in coated pellets – Effect of coating on API crystallinity
European Journal of Pharmaceutical Sciences, Volume 48, Issue 3, 14 February 2013, Pages 563-571
Krisztina Nikowitz, Klára Pintye-Hódi, Géza Regdon Jr.

Research article
The influence of rolling friction on the shear behaviour of non-cohesive pharmaceutical granules – An experimental and numerical investigation
European Journal of Pharmaceutical Sciences, Volume 49, Issue 2, 13 May 2013, Pages 241-250
Ann-Sofie Persson, Göran Frenning

Research article
Characteristics of pellet flow in a Wurster coater draft tube utilizing piezoelectric probe
Powder Technology, Volume 235, February 2013, Pages 640-651
Matevž Luštrik, Rok Šibanc, Stanko Srčič, Matjaž Perpar, Iztok Žun, Rok Dreu

Research article
Estimating coating quality parameters on the basis of pressure drop measurements in a Wurster draft tube
Powder Technology, Volume 246, September 2013, Pages 41-50
Matjaž Perpar, Matevž Luštrik, Rok Dreu, Stanko Srčič, Iztok Žun

Research article
Influence of Non-Water-Soluble Placebo Pellets of Different Sizes on the Characteristics of Orally Disintegrating Tablets Manufactured by Freeze-Drying
Journal of Pharmaceutical Sciences, Volume 102, Issue 6, June 2013, Pages 1786-1799
Ulrike Stange, Christian Führling, Henning Gieseler

List – Publications with MCC spheres, 2012

Research article
A density-based segmentation for 3D images, an application for X-ray micro-tomography
Analytica Chimica Acta, Volume 725, 6 May 2012, Pages 14-21
Thanh N. Tran, Thanh T. Nguyen, Tofan A. Willemsz, Gijsvan Kessel, Henderik W. Frijlink, Kees van der Voort Maarschalk

Research article
Attrition and abrasion resistance of particles coated with pre-mixed polymer coating systems
Powder Technology, Volume 230, November 2012, Pages 1-13
G. Perfetti, F. Depypere, S. Zafari, P. van Hee, W.J. Wildeboer, G. M. H. Meesters

Research article
New spout-fluid bed apparatus for electrostatic coating of fine particles and encapsulation
Powder Technology, Volume 225, July 2012, Pages 52-57
Roman G. Szafran, Wojciech Ludwig, Andrzej Kmiec

Research article
Particle size and packing characterization by diffuse light transmission
Particuology Volume 10, Issue 5, October 2012, Pages 619-627
Henrik Ehlers, Jyrki Heinämäki, Jouko Yliruusi

Research article
Dry Powder Coating in a Modified Wurster Apparatus
Procedia Engineering, Volume 42, 2012, Pages 437-446
W. Ludwig, R.G. Szafran, A. Kmiec, J. Dziak

Research article
Attrition strength of water-soluble cellulose derivative coatings applied on different core materials
Powder Technology, Volume 222, May 2012, Pages 71-79
Katarzyna Nienaltowska, Frédéric Depypere, Giacomo Perfetti, Gabrie M.H. Meesters, Frederik Ronsse, Jan G. Pieters, Koen Dewettinck

Research article
An experimental evaluation of the accuracy to simulate granule bed compression using the discrete element method
Powder Technology, Volume 219, March 2012, Pages 249-256
Ann-Sofie Persson, Göran Frenning

List – Publications with MCC spheres, 2011

Research article
Understanding Fluidized-Bed Granulation
Pharmaceutical Technology 35 (8), 2011, 63-67
A. Burggraeve, T. Van Den Kerkhof, M. Hellings, J.P. Remon, C. Vervaet, T. De Beer

Research article
Dry particle high coating of biopowders: An energy approach
Powder Technology, Volume 208, Issue 2, 25 March 2011, Pages 378-382
S. Otles, O. Lecoq, J. A. Dodds

Research article
A density based segmentation method to determine the coordination number of a particulate system
Chemical Engineering Science, Volume 66, Issue 24, 15 December 2011, Pages 6385-6392
Thanh T. Nguyen, Thanh N. Tran, Tofan A. Willemsz, Henderik W. Frijlink, Tuomas Ervasti, Jarkko Ketolainen, Kees van der Voort Maarschalk

Research article
Study of the preparation of a multiparticulate drug delivery system with a layering technique
Powder Technology, Volume 205, Issues 1–3, 10 January 2011, Pages 155-159
Krisztina Nikowitz, Péter Kása Jr., Klára Pintye-Hódi, Géza Regdon Jr.

Research article
Effect of annealing time and addition of lactose on release of a model substance from Eudragit® RS coated pellets produced by a fluidized bed coater
Chemical Engineering Research and Design, Volume 89, Issue 6, June 2011, Pages 697-705
Ulrich M. Heckötter, Anette Larsson, Pornsak Sriamornsak, Mont Kumpugdee-Vollrath

Research article
Suspension pellet layering using PVA–PEG graft copolymer as a new binder
International Journal of Pharmaceutics, Volume 412, Issues 1–2, 30 June 2011, Pages 28-36
L. Suhrenbrock, G. Radtke, K. Knop, P. Kleinebudde

Research article
In-line particle sizing for real-time process control by fibre-optical spatial filtering technique (SFT)
Advanced Powder Technology, Volume 22, Issue 2, March 2011, Pages 203-208
Petrak Dieter, Dietrich Stefan, Eckardt Günter, Köhler Michael

Research article
Flowability of surface modified pharmaceutical granules: A comparative experimental and numerical study
European Journal of Pharmaceutical Sciences, Volume 42, Issue 3, 14 February 2011, Pages 199-209
Ann-Sofie Persson, Göran Alderborn, Göran Frenning

List – Publications with MCC spheres, 2010

Research article
Labscale fluidized bed granulator instrumented with non-invasive process monitoring devices
Chemical Engineering Journal, Volume 164, Issues 2–3, 1 November 2010, Pages 268-274
Jari T. T. Leskinen, Matti-Antero H. Okkonen, Maunu M. Toiviainen, Sami Poutiainen, Mari Tenhunen, Pekka Teppola, Reijo Lappalainen, Jarkko Ketolainen, Kristiina Järvinen

Research article
X-ray micro tomography and image analysis as complementary methods for morphological characterization and coating thickness measurement of coated particles
Advanced Powder Technology, Volume 21, Issue 6, November 2010, Pages 663-675
Giacomo Perfetti, Elke Van de Casteele, Bernd Rieger, Willem J. Wildeboer, Gabrie M.H. Meesters

Research article
New insights into segregation during tabletting
International Journal of Pharmaceutics, Volume 397, Issues 1–2, 15 September 2010, Pages 19-26
S. Lakio, S. Siiriä, H. Räikkönen, S. Airaksinen, T. Närvänen, O. Antikainen, J.Yliruusi

Research article
Evaluation of in-line spatial filter velocimetry as PAT monitoring tool for particle growth during fluid bed granulation
European Journal of Pharmaceutics and Biopharmaceutics, Volume 76, Issue 1, September 2010, Pages 138-146
A. Burggraeve, T. Van Den Kerkhof, M. Hellings, J.P. Remon, C. Vervaet, T. De Beera

Research article
Granule size distribution of tablets
Journal of Pharmaceutical Sciences, Volume 99, Issue 4, April 2010, Pages 2061-2069
Satu Virtanen, Osmo Antikainen, Heikki Räikkönen, Jouko Yliruusi

Research article
Colorful Drying
AAPS PharmSciTech 11, 46–53 (2010); doi: 10.1208/s12249-009-9351-x
S. Lakio, J. Heinämäki, J. Yliruusi

Short communication
Can encapsulation lengthen the shelf-life of probiotic bacteria in dry products?
International Journal of Food Microbiology, Volume 136, Issue 3, 1 January 2010, Pages 364-367
F. Weinbreck, I. Bodnár, M.L. Marco

List – Publications with MCC spheres, 2009

Research article
Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads
European Journal of Pharmaceutical Sciences, Volume 37, Issue 1, 11 April 2009, Pages 1-10
Chon gFan, Rashmi Pai-Thakur, Wantanee Phuapradit, Lin Zhang, Hung Tian, Waseem Malick, Navnit Shah, M. Serpil Kislalioglu

Short communication
Raman spectroscopic investigation of film thickness
Polymer Testing, Volume 28, Issue 7, October 2009, Pages 770-772
T. Sovány, K. Nikowitz, G. Regdon Jr., P. Kása Jr., K. Pintye-Hódi

Research article
In vivo evaluation of the vaginal distribution and retention of a multi-particulate pellet formulation
European Journal of Pharmaceutics and Biopharmaceutics, Volume 73, Issue 2, October 2009, Pages 280-284
Nele Poelvoorde, Hans Verstraelen, Rita Verhelst, Bart Saerens, Ellen De Backer, Guido Lopes dos Santos Santiago, Chris Vervaet, Mario Vaneechoutte, Fabienne De Boeck, Luc Van Borteld, Marleen Temmerman, Jean-Paul Remon

Research article
Modulating pH-independent release from coated pellets: Effect of coating composition on solubilization processes and drug release
European Journal of Pharmaceutics and Biopharmaceutics, Volume 72, Issue 1, May 2009, Pages 111-118
Simon Ensslin, Klaus Peter Moll, Hendrik Metz, Markus Otz, Karsten Mäder

Research article
Dry Particle High-Impact Coating of Biopowders: Coating Strength
Particulate Science and Technology, Volume 27(4), 2009
S. Ötles, O. Lecoq, J. A. Dodds


Research article

Book
Formulation and Analytical Development for Low-Dose Oral Drug Products
John Wiley & Sons , inc. (2009), ISBN 978-0-470-05609-7
Jack Zheng (Editor)

List – Publications with MCC spheres, 2008 and earlier

Research article
Attrition strength of different coated agglomerates
Chemical Engineering Science, Volume 63, Issue 5, March 2008, Pages 1361-1369
B. van Laarhoven, S.C.A. Wiers, S.H. Schaafsma, G.M.H. Meesters

Research article
Direct Drug Loading into Preformed Porous Solid Dosage Units by the Controlled Particle Deposition (CPD), a New Concept for Improved Dissolution Using SCF-Technology
Journal of Pharmaceutical Sciences, Volume 97, Issue 10, October 2008, Pages 4416-4424
Ragna S. Wischumerski, Michael Türk, Martin A. Wahl

Research article
Optimisation of an enteric coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis
European Journal of Pharmaceutics and Biopharmaceutics, Volume 69, Issue 3, August 2008, Pages 969-976
Nele Poelvoorde, Nathalie Huyghebaert, Chris Vervaet, Jean-Paul Remon

Research article
Dynamic rearrangement of disulfide bridges influences solubility of whey protein coatings
International Dairy Journal, Volume 18, Issue 5, May 2008, Pages 566-573
René Floris, Igor Bodnár, Fanny Weinbreck, Arno C. Alting

Research article
New insight into modified release pellets – Internal structure and drug release mechanism
Journal of Controlled Release, Volume 128, Issue 2, 4 June 2008, Pages 149-156
Simon Ensslin, Klaus Peter Moll, Kurt Paulus, Karsten Mäder

Research article
Development of an enteric-coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis
European Journal of Pharmaceutics and Biopharmaceutics, Volume 61, Issue 3, October 2005, Pages 134-141
Nathalie Huyghebaert, An Vermeire, Pieter Rottiers, Erik Remaut, Jean Paul Remon

Research article
Evaluation of extrusion/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis
European Journal of Pharmaceutics and Biopharmaceutics, Volume 59, Issue 1, January 2005, Pages 9-15
Nathalie Huyghebaert, An Vermeire, Sabine Neirynck, Lothar Steidler, Eric Remaut, Jean Paul Remon

Research article
Liquid absorption capacity of carriers in the food technology
Powder Technology, Volume 134, Issue 3, 30 September 2003, Pages 201-209
Heidi Lankes, Karl Sommer, Bernd Weinreich

 

Chewable formulations with MCC starter cores

Chewable formulations with MCC starter cores: Patient-centric design and pharmaceutical relevance

Chewable formulations with MCC starter cores are an advanced oral dosage form that combines patient-friendly administration with robust pharmaceutical performance. Thereby, patient refers includes humans and non-human mammalian animals, such as dogs, cats, mice, rats, guinea pigs, rabbits, ferrets, cows, horses, sheep, goats, and pigs. At the outset, these formulations address a key challenge in drug therapy, namely patient compliance, by offering a dosage form that patients can chew without water. Consequently, they are particularly suitable for pediatric, geriatric, and veterinary applications. Moreover, chewable dosage forms allow formulators to improve taste, mouthfeel, and ease of use, which directly supports adherence to therapy. At the same time, MCC starter cores provide excellent mechanical stability, uniformity, and processing reliability. Therefore, they enable consistent drug loading, predictable disintegration, and scalable manufacturing. As a result, this combination creates significant opportunities for modern, patient-centric drug delivery.

Chewable formulations with MCC starter cores according to WO2022049149A1

The patent WO2022049149A1 describes chewable pharmaceutical compositions designed to disintegrate rapidly while maintaining acceptable texture and stability. In particular, the invention focuses on soft chewable dosage forms that contain at least one active pharmaceutical ingredient together with carbonate or bicarbonate compounds that act as efficient disintegrants. As a result, the dosage form breaks down quickly when exposed to aqueous or gastric media. This rapid disintegration directly supports fast and reproducible dissolution of the API. Furthermore, the patent emphasizes that surface structure, porosity, and wettability of the chewable matrix strongly influence drug release. Therefore, careful control of formulation and processing parameters becomes essential. The disclosed chewable products typically achieve disintegration within pharmacopeial limits and release a high proportion of the API within short dissolution times. In addition, the patent highlights the importance of balancing lipophilic excipients, since excessive hydrophobicity can delay disintegration. Consequently, the invention aims to deliver chewable dosage forms that combine good palatability with reliable pharmaceutical performance. Overall, the patent demonstrates how optimized excipient systems can overcome common limitations of chewable drugs while improving patient acceptance.

Chewable formulations with MCC starter cores

Chewable formulations with MCC starter cores

Advances, dissolution considerations, and API challenges in chewable dosage forms

Chewable formulations with MCC starter cores illustrate clear advances in chewable drug technology. First, the use of spherical MCC cores supports multiparticulate designs that improve content uniformity and process robustness. Moreover, these cores enable precise API layering, which enhances dose accuracy and reproducibility. When considering dissolution profiles, formulators must carefully manage core porosity, disintegrant efficiency, and wettability. Therefore, rapid liquid penetration and controlled matrix breakdown remain critical success factors. At the same time, APIs in chewable formulations face both obstacles and opportunities. On one hand, taste masking, stability, and dissolution control present technical challenges. On the other hand, chewable formats open new possibilities for poorly compliant patient groups and combination therapies. Consequently, successful products require a well-balanced formulation strategy that aligns API properties with excipient functionality.

Role of CELLETS® in the context of this patent

Although WO2022049149A1 does not explicitly name commercial products, its technical concept strongly aligns with MCC starter cores such as CELLETS® 100 (100-200 µm) and CELLETS® 200 (200-355 µm). These microcrystalline cellulose spheres offer high sphericity, low friability, and narrow particle size distribution. Therefore, they provide an ideal substrate for API layering in chewable multiparticulate systems. CELLETS® 100 and CELLETS® 200 support uniform coating, predictable dissolution behavior, and efficient processing in fluidized bed systems. In addition, their inert and tasteless nature helps minimize interactions with APIs and flavoring agents. As a result, they play a crucial functional role in achieving stable, reproducible, and patient-acceptable chewable formulations.

Conclusion and outlook for chewable formulations with MCC starter cores

Chewable formulations with MCC starter cores represent a strategic convergence of patient-centric design and pharmaceutical engineering. In conclusion, the integration of MCC starter cores enhances manufacturing reliability, dose uniformity, and dissolution performance while supporting improved patient compliance. Moreover, patents such as WO2022049149A1 demonstrate how modern excipient systems can overcome traditional limitations of chewable dosage forms. Looking ahead, further innovation will likely focus on advanced taste-masking technologies, tailored dissolution profiles, and broader API compatibility. Therefore, chewable formulations with MCC starter cores are well positioned to play an increasingly important role in future oral drug delivery.

Patent Summary

  • Name of Patent: Chewable formulations
  • Patent Number: WO2022049149A1
  • Year of Patent: 2021
  • Patent Holders: Clément Maxime Chevreau, Pascal Grenier, Claudia Reitz
  • Affiliation: Elanco Tiergesundheit AG
Enzyme-cleavable methadone prodrugs Innovations in formulation

Enzyme‑cleavable methadone prodrugs: Functionality, Opportunities, and Summary of US20250361205A1

Introduction to Enzyme‑cleavable methadone prodrugs

Enzyme‑cleavable methadone prodrugs represent a novel class of pharmacological agents designed to provide controlled release of methadone only after specific enzymatic activation. These prodrugs attach an enzyme‑cleavable promoiety to the methadone molecule, rendering it inactive until a target enzyme cleaves the linkage in vivo. This mechanism reduces misuse potential and provides more predictable pharmacokinetics compared to conventional methadone formulations. By depending upon specific enzymatic activity, this prodrug design can improve safety and minimize risks associated with inappropriate administration or overdose, while maintaining therapeutic efficacy for opioid dependence or chronic pain management.

Beyond safety, enzyme‑cleavable methadone prodrugs offer opportunities in advanced drug formulation. They enable precise control over the timing and extent of methadone release based on the activity of endogenous enzymes. As a result, formulators can tailor release rates and reduce systemic peaks that commonly contribute to adverse effects or abuse. These prodrugs also permit formulation with excipients or technologies that further modulate release profiles, including multiparticulate systems or coatings. In addition, controlled enzyme activation provides a strategy to optimize oral delivery, enhance patient compliance, and potentially reduce the burden of supervised dosing programs in opioid maintenance therapy.

Summary of this patent

The patent application US20250361205A1 discloses enzyme‑cleavable methadone prodrugs and corresponding methods of use, focusing on prodrugs that deliver methadone through enzymatically‑controlled release. These prodrugs contain a promoiety linked to methadone that requires cleavage by specific enzymes, such as digestive proteases, before the active opioid is liberated. By requiring enzymatic cleavage followed by intramolecular cyclization to release active methadone, the design significantly lowers the susceptibility to accidental or intentional misuse, including inappropriate routes of administration or chemical tampering.

The disclosed prodrug moieties can include amino acid residues or peptides of up to about 100 amino acids linked via an amide bond to the methadone nitrogen. By selecting promoieties that are substrates for particular enzymes, formulators can adjust release kinetics based on the target enzyme’s activity and distribution. For example, gastrointestinal enzymes like trypsin are contemplated as triggers for prodrug activation. The application also describes including enzyme inhibitors in the pharmaceutical composition to attenuate the rate of enzymatic cleavage when desired. This addition can further control release profiles and reduce unintended rapid activation.

The patent describes general chemical structures of enzyme‑cleavable methadone prodrugs, outlining variations in functional groups and linkers that influence both stability and enzymatic susceptibility. These structures include several formulae (e.g., MD‑(I), MD‑(II), MD‑(III)), each representing different classes of promoieties attached to the methadone core. Notably, upon enzymatic cleavage of the promoiety, a stable cyclic urea or other cyclic group forms, which is pharmaceutically acceptable and of low toxicity. The description also covers pharmaceutically acceptable salts, solvates, and crystalline forms of the prodrugs, enhancing formulation versatility.

A key advantage emphasized in this disclosure is the reduction of excessive plasma methadone levels when the prodrug is administered improperly. Because the prodrug cannot be converted to methadone without specific enzymatic action and cyclization, the risk of overdose is reduced. Furthermore, the document details that trypsin inhibitors or other enzyme modulators may be co‑formulated to regulate the enzymatic activation rate. In addition to the chemical and pharmacokinetic considerations, the application mentions pharmaceutical compositions that include typical excipients, such as fillers, binders, and disintegrants, that support conventional formulation processes for oral delivery.

Use of CELLETS® in This Context

Although CELLETS® (highly spherical microcrystalline cellulose pellets used as starter cores in multiparticulate drug delivery systems) are not explicitly referenced in US20250361205A1, the broader formulation context suggests potential relevance. CELLETS® provide uniform and inert starter cores that support controlled layering of active pharmaceutical ingredients. In multiparticulate systems, CELLETS® improve coating uniformity, flow properties, and controlled release profiles in oral dosage forms. These characteristics make them useful for advanced prodrug formulations where release kinetics and consistency are critical, particularly when precise layering of enzyme‑cleavable prodrug moieties is required. Unlike conventional inert cores, CELLETS® enable predictable performance and facilitate scalable manufacturing for complex oral formulations.

In this patent, some particle sizes of CELLETS® are explicitely named:

Type Particle size distribution
(≥ 85 %)
learn more
CELLETS® 100 100-200 µm
(150/80)
more information
CELLETS® 200 200-355 µm
(80/50)
more information
CELLETS® 350 350-500 µm
(50/35)
more information
CELLETS® 500 500-710 µm
(35/25)
more information
CELLETS® 700 700-1000 µm
(25/18)
more information
CELLETS® 1000 1000-1400 µm
(18/13)
more information

Conclusion and Outlook

In summary, enzyme‑cleavable methadone prodrugs offer a promising advancement in opioid therapy and formulation science, combining controlled enzymatic activation with enhanced safety. The patent US20250361205A1 details chemical constructs and methods that reduce misuse potential and allow sophisticated control of drug release. Given ongoing needs for safer opioid medications, these prodrugs could transform maintenance therapy and pain management by minimizing overdose risks and improving patient compliance. Looking forward, integrating technologies such as multiparticulate delivery systems and optimized excipients (e.g., CELLETS®) will further refine dosing precision and therapeutic outcomes. Future research and clinical evaluation will determine how these designs perform in real‑world settings, including their impact on pharmacokinetics, abuse deterrence, and commercial viability.

Patent Summary

  • Name of Patent: Enzyme-cleavable methadone prodrugs and methods of use thereof
  • Patent Number: US20250361205A1
  • Year of Patent: 2025
  • Patent Holders: Lynn Kirkpatrick
  • Affiliation: Ensysce Biosciences Inc.

Enzyme-cleavable methadone prodrugs Innovations in formulation

hydroxynorketamine modified-release dosage form ChatGPT Image 11. Juli 2025, 13_57_57

Introduction

The development of a hydroxynorketamine modified-release dosage form marks an important advance in neuropsychiatric therapy. Hydroxynorketamine (HNK), a ketamine metabolite, shows rapid antidepressant activity through mechanisms different from ketamine itself. It works mainly by modulating α7-nicotinic acetylcholine receptors and activating mTOR pathways.

This targeted action makes HNK a strong candidate as an active pharmaceutical ingredient with a favorable safety profile. Unlike ketamine, it avoids dissociative and addictive side effects. A modified-release form built with CELLETS®—uniform spherical pellets—offers tighter therapeutic control. It sustains plasma concentration, reduces peak-to-trough swings, and helps patients stay consistent with treatment.

In addition, the inert cores often range between 100 and 500 μm in size. A more refined range of 200 to 400 μm improves precision. About 90% of particles fall within this window, confirmed by sieve analysis. One example is CELLETS® 200, which demonstrates this particle size distribution effectively.

API Function and Patient Benefits

Hydroxynorketamine mainly acts by inhibiting α7-nicotinic receptors. This lowers intracellular Ca²⁺ and D-serine levels and reduces NMDA receptor excitotoxicity. At the same time, it boosts mTOR signaling and strengthens AMPA receptor function.

Together, these effects speed up synaptogenesis and create fast antidepressant responses. Evidence comes from both preclinical studies and early clinical findings. For patients, this means rapid mood elevation without ketamine-related side effects. Unlike ketamine, it does not cause hallucinations or carry strong abuse potential.

From a pharmacokinetic view, a modified-release dosage form improves consistency in therapy. It also simplifies dosing schedules and increases tolerability.

Modified‑release dosage Formulation with CELLETS®

The incorporation of CELLETS® into the modified‑release formulation provides several benefits. Their uniform size and high sphericity ensure consistent drug coating and predictable release. CELLETS® also enable multiparticulate dosing, which reduces variability and allows tailored release profiles.

For hydroxynorketamine (HNK), CELLETS® can carry specific polymer coatings such as ethylcellulose or Eudragit. These coatings dissolve or erode at controlled rates, releasing the API steadily over time. This method lowers peak systemic concentrations, which reduces side effects while maintaining efficacy.

Additionally, CELLETS® support monolithic layering or reservoir systems. This setup allows complex release patterns, such as an initial burst followed by sustained delivery. Such profiles are ideal for achieving a rapid onset and maintaining antidepressant effects in depression treatment.

Key Findings on Hydroxynorketamine modified‑release dosage form

In the disclosed patent (US 2025 0177325 A1), researchers describe a multiparticulate modified‑release system for hydroxynorketamine. They use CELLETS® as the core substrate. The CELLETS® carry successive polymer layers that control drug release. This design produces an initial release phase followed by prolonged delivery.

Pharmacokinetic modeling shows a flattened plasma-concentration profile, lower maximum concentration (Cmax), longer time to peak (Tmax), and higher area under the curve (AUC). Together, these factors maintain therapeutic HNK levels over time. This steady exposure may reduce rebound symptoms and cut dosing frequency. As a result, patient adherence improves, and treatment regimens may shift to once-daily or even less frequent dosing.

Conclusion and Outlook

In conclusion, the hydroxynorketamine modified‑release dosage form using CELLETS® offers a promising pharmaceutical approach. It leverages HNK’s unique mechanism as a non-dissociative antidepressant. Controlled release maximizes its clinical potential.

Cellet-based formulations improve pharmacokinetics, enhance tolerability, and increase convenience. These benefits could significantly help patients with treatment-resistant depression. Further work is needed, including in vitro−in vivo correlation studies, polymer selection optimization, and confirmatory clinical trials.

Looking ahead, this technology may expand HNK applications to other neuropsychiatric or neurodegenerative disorders. It provides a refined dosage form that meets both patient needs and therapeutic goals.

Patent Details

  • Name or patent: Hydroxynorketamine for the use in the treatment of depression
  • Patent number: US 20250177325 A1
  • Year of patent: 2025
  • Patent holder names and affiliation: (Names not specified in public abstract; likely the inventors assigned to their sponsoring institution or company as listed in patent document)

This summary underscores the innovative use of CELLETS® in creating a refined hydroxynorketamine modified-release dosage form that elevates both therapeutic performance and patient-centric outcomes.

hydroxynorketamine modified-release dosage form
microcrystalline cellulose for organic pollutants adsorption

Introduction

Fixed-bed column adsorption is an essential process in modern water treatment systems, widely implemented due to its continuous operation, ease of design, and applicability in large-scale systems. In this method, a contaminant-laden liquid passes through a column packed with adsorbent material, facilitating efficient contaminant removal before discharge or reuse. While effective for many pollutants, the removal of organic dyes—particularly synthetic types such as Methylene Blue—remains a formidable challenge due to their structural complexity, high solubility, and resistance to conventional degradation methods. These characteristics are especially problematic in pharmaceutical applications, where effluents must meet strict regulatory limits to prevent environmental and product contamination.

Organic dyes in pharmaceutical wastewater not only hinder downstream purification but also pose ecotoxicological risks when released into natural water bodies. As such, there is an ongoing demand for adsorbent materials that are effective, regenerable, and environmentally friendly. Within this framework, microcrystalline cellulose for organic pollutants adsorption represents a promising and sustainable approach.

Use of CELLETS® and experimental design

In the study referenced by DOI 10.5004/dwt.2019.23638 [1], researchers evaluated microcrystalline cellulose-based spherical pellets—commercially known as CELLETS® —for their potential to adsorb organic dyes from aqueous solutions. These pellets are manufactured via wet-granulation and extrusion processes, yielding highly uniform, spherical particles with low friability and high surface area. Such properties are ideal for both batch and dynamic (fixed-bed) adsorption studies due to predictable flow behavior and minimal mechanical breakdown under continuous operation.

Batch experiments were initially conducted using Methylene Blue as a model compound. Isotherm analysis revealed strong agreement with the Langmuir model, indicating monolayer adsorption with a maximum capacity of approximately 82 mg/g. Kinetic modeling confirmed that adsorption followed pseudo-second-order dynamics, suggesting chemisorption mechanisms dominated the process.

Key findings

The results showed that microcrystalline cellulose pellets offer a high specific adsorption capacity for Methylene Blue dye, consistent with Langmuir isotherm behavior. The pseudo-second-order kinetic model provided the best fit for experimental data, supporting a chemisorption-driven process. Notably, the physical structure of the CELLETS® 200 remained intact after multiple uses, and regeneration with dilute acids such as acetic and sulfuric acid restored a significant portion of the adsorption capacity without compromising structural integrity. These findings validate the use of microcrystalline cellulose for organic pollutants adsorption, especially where material longevity and repeat usability are essential.

Regeneration cycles and sustainability

One of the critical advantages of CELLETS® lies in their capacity for multiple regeneration cycles. The study demonstrated that after five adsorption-desorption cycles, more than 85% of the original adsorption capacity was retained, especially when 0.01 mol/L sulfuric acid was used as the desorbing agent. Minimal structural degradation was observed, which confirms the material’s resilience to chemical treatment. The efficient desorption and structural stability make these cellulose-based adsorbents both economically and environmentally viable, reducing the need for frequent replacement and waste generation—a key factor in large-scale industrial settings.

Column-scale modeling

Though the primary focus was on batch experiments, the implications of the findings extend to column-scale applications. The authors suggest that due to the spherical shape and low pressure drop of CELLETS®, these materials are ideally suited for packed-bed column use. Future studies are encouraged to employ dynamic modeling approaches such as Thomas, Yoon–Nelson, or Bohart–Adams models to predict breakthrough behavior under continuous flow. Such models would enable optimization of operational parameters (e.g., flow rate, bed height, and influent concentration) and facilitate scale-up for industrial applications.

The material’s excellent flowability and structural uniformity ensure homogeneous packing and minimized channeling—common issues in poorly engineered adsorbent beds. These features underscore the practical applicability of microcrystalline cellulose for organic pollutants adsorption in fixed-bed column configurations.

Comparative performance

Compared to other low-cost and industrial adsorbents—such as activated carbon, bentonite clay, or synthetic resins—microcrystalline cellulose offers several advantages. While activated carbon exhibits higher adsorption capacity per gram, it suffers from high cost, complex regeneration, and variable quality. Conversely, cellulose-based materials are biodegradable, inexpensive, and easier to functionalize chemically if needed.

Moreover, unlike biomass-based powders (e.g., sawdust or peanut shells), CELLETS® provide consistent performance due to controlled manufacturing processes. Their uniform size, sphericity, and mechanical strength reduce operational issues like clogging and channel formation in dynamic systems. These comparative strengths position microcrystalline cellulose for organic pollutants adsorption as a versatile solution in both environmental and industrial water treatment sectors.

Conclusion and outlook

The study presents compelling evidence for the effective use of CELLETS®, a form of microcrystalline cellulose, in the adsorption of organic pollutants such as Methylene Blue. With a high uptake capacity, favorable kinetic behavior, excellent reusability, and strong structural integrity, these cellulose-based pellets are well-suited for sustainable wastewater treatment applications. Their compatibility with both batch and fixed-bed systems broadens their potential for industrial implementation.

Looking ahead, further investigations should focus on scaling the process to pilot and industrial levels, applying column modeling techniques to optimize system design. Additionally, exploring chemical modifications to enhance selectivity and adsorption performance against a wider range of organic pollutants—including pharmaceutical residues and endocrine-disrupting compounds—will further elevate the role of microcrystalline cellulose for organic pollutants adsorption in advanced water treatment technologies.

References

[1] Daniela Suteu, Gabriela Biliuta, Lacramioara Rusu, Sergiu Coseri, Christophe Vial, Iulia Nica (Nebunu), Desalination and Water Treatment Volume 146, April 2019, Pages 176-187, doi:10.5004/dwt.2019.23638.

CELLETS as new type of adsorbent

Abstract

CELLETS, a new type of adsorbent, have emerged as a promising solution in water treatment. They are particularly effective in fixed-bed column systems for removing persistent organic pollutants, such as synthetic dyes. This summary reflects research published by Suteu et al. [1].

Fixed-bed adsorption is a well-established filtration method. It allows continuous treatment of contaminated water by passing it through a packed column filled with adsorbent material. Its advantages include high throughput, easy operation, scalability, and adaptability to various industrial settings. However, one enduring challenge is the effective removal of dyes. These molecules, especially from pharmaceutical and chemical effluents, have complex aromatic structures, high chemical stability, and resistance to biodegradation.

Dyes, both cationic and anionic, are not only visually polluting but also potentially toxic, mutagenic, or carcinogenic. In pharmaceutical wastewater, even trace levels can disrupt downstream processes or contaminate the environment. Consequently, this raises concerns for human and ecological health. Conventional adsorbents, such as activated carbon and ion-exchange resins, are effective but have limitations. They are costly, inefficient to regenerate, and prone to fouling.

In this context, microcrystalline cellulose (MCC) cellets offer a novel approach. Their spherical shape, uniform particle size, mechanical resilience, and hydrophilic surface make them suitable for packed-bed applications. This study examines cellets’ performance in removing representative dyes from aqueous media. By focusing on CELLETS as a new type of adsorbent, the research addresses a critical gap. It offers a sustainable, cost-effective, and scalable solution for dye-laden industrial wastewater, particularly under the stringent requirements of the pharmaceutical sector.

Introduction

Fixed-bed column techniques are essential filtration systems. In these systems, a fluid stream passes continuously through a packed bed of adsorbent material. They are valued for operational simplicity, scalability, and continuous processing—key features for industrial and pharmaceutical wastewater treatment. However, removing dyes remains a major challenge. These molecules are complex, often toxic, and chemically stable, resisting conventional treatment. In pharmaceutical effluents, even trace dye residues can pose serious safety risks and violate strict regulatory limits.

This study investigates CELLETS® as a new type of adsorbent in fixed-bed columns. CELLETS® are spherical microcrystalline cellulose pellets. They are tested for their ability to remove both cationic and anionic dyes from aqueous streams. Thanks to their uniform geometry, mechanical strength, and biocompatibility, CELLETS® show promise in overcoming the limitations of current dye removal methods.

Use of cellulose CELLETS as new type of adsorbent

CELLETS® are uniformly sized spherical pellets made of microcrystalline cellulose. They are typically available in diameters ranging from 100 µm to 500 µm. Their narrow size distribution, smooth surface, and water-insoluble nature reduce friability and minimize clogging. As a result, they are ideal for packed-bed applications [1]. In this study, CELLETS® 200 and CELLETS® 350 served as the fixed-bed medium.

First, the authors characterized their morphology, including sphericity, porosity, and mechanical stability. Then, they applied CELLETS® in fixed-bed column experiments to remove model dyes: Methylene Blue (cationic) and Brilliant Red HE‑3B (anionic).

Additionally, batch experiments were performed to establish equilibrium, kinetics, and isotherm parameters before column testing. In the fixed-bed setup, breakthrough curves were recorded under different operational conditions, such as flow rate, bed height, and influent dye concentration. These tests revealed how CELLETS® perform under dynamic conditions.

Key Findings

The study revealed that CELLETS® exhibit strong adsorption capabilities for both cationic and anionic dyes, performing comparably to other biosorbents used in dynamic treatment systems. The breakthrough curves demonstrated that column performance could be modulated by operational parameters: increasing bed height extended breakthrough time and improved capacity, while higher flow rates accelerated breakthrough due to mass transfer limitations. Mathematical models commonly used for fixed-bed adsorption (Thomas, Yoon–Nelson, Bohart–Adams) fit the experimental data well, enabling the extraction of key design parameters for scale-up. Notably, CELLETS® displayed mechanical robustness, sustaining repeated adsorption–desorption cycles (through mild acid or ethanol washout) with over 80 % retention of initial capacity [1,2]. Their spherical geometry resulted in low pressure drop and uniform flow, mitigating common issues like channeling and bed compaction.

Conclusion & Outlook

This study convincingly positions CELLETS® as a compelling new type of adsorbent for dye removal in fixed-bed systems. Their blend of favorable adsorptive properties, structural resilience, and hydraulic stability make them attractive for continuous water treatment processes, especially where regulatory constraints demand high effluent quality. The renewable nature of microcrystalline cellulose adds environmental value, aligning with sustainable treatment practices.

Future research directions include enhancing CELLETS®’ adsorption capacity via surface functionalization (e.g., with carboxyl or amine moieties) to target specific pollutants, extending studies with real industrial and pharmaceutical effluents, and integrating CELLETS®-based systems with complementary treatment processes such as membrane filtration or advanced oxidation. Pilot-scale studies and economic assessments will be essential to advance CELLETS® from lab-scale validation to industrial adoption.

By demonstrating CELLETS® as new type of adsorbent, this publication highlights their promising role in addressing the persistent challenge of dye removal in fixed-bed column systems—offering a scalable, effective, and sustainable solution for complex aqueous pollution.

References

[1] Environmental Engineering and Management Journal, 2015, Vol.14, No. 3, 525-532; http://www.eemj.icpm.tuiasi.ro/pdfs/vol14/no3/full/4_998_Suteu_14.pdf

[2] Fixed-bed-column studies for methylene blue removal by CELLETS

[3] Renewable Resource Biosorbents: Granulated Cellulose CELLETS 200 for Organic Pollutants Adsorption in Fixed-Bed Column Systems, Separations 2023, 10(2), 143; doi:10.3390/separations10020143

Cellets 200 for organic pollutants adsorption

Introduction

Fixed-bed column techniques are widely applied in water and wastewater treatment to achieve continuous adsorption of pollutants. In these systems, aqueous effluent flows through a packed bed of adsorbent material, offering operational simplicity, easy scale-up, and consistent performance—critical features in industrial and pharmaceutical settings. However, removing dyes from pharmaceutical effluents presents unique challenges: dyes are structurally complex, resistant to biodegradation, and often toxic or carcinogenic even at trace levels. Pharmaceutical industries demand exceptionally high water quality, making dye removal both technically difficult and economically significant.

This study evaluates granulated cellulose CELLETS® 200 for organic pollutants adsorption in fixed-bed systems. CELLETS® 200, composed of microcrystalline cellulose, are spherical pellets with defined particle size and porosity, designed to serve as a sustainable biosorbent. Their uniform granulation minimizes bed channeling and pressure drop—common operational issues—while their renewable nature supports greener treatment practices.

Use of CELLETS® 200 for organic pollutants adsorption

In the reported research, Granulated CELLETS® 200 were packed into vertical fixed-bed columns to treat aqueous solutions containing model organic dyes. Prior to column testing, batch experiments were used to determine equilibrium and kinetic parameters, ensuring reliable interpretation of breakthrough behavior. Columns were operated under controlled conditions—including flow rate, temperature (20 °C), and influent concentration—to monitor how CELLETS® 200 performed dynamically. Breakthrough curves were generated to assess adsorption capacity over time, and mathematical models (Thomas, Yoon–Nelson, Bohart–Adams) were applied to approximate performance and guide scale-up efforts.

Key Findings

Granulated cellulose CELLETS® 200 demonstrated effective uptake of cationic dyes such as Methylene Blue in a continuous-flow setup. The fixed-bed columns showed clear breakthrough profiles: bed depth and lower flow rates correlated with delayed breakthrough and increased total adsorption, confirming that the system response is highly dependent on operational variables. The experimental breakthrough data matched well with established fixed-bed adsorption models, suggesting predictable performance in larger-scale applications. Additionally, the mechanical integrity of CELLETS® 200—owing to their spherical shape and granulated structure—ensured low pressure drop and mitigated flow channeling even over extended operation. The study also underscored that CELLETS® 200 can be regenerated through mild washing treatments, maintaining a significant fraction of their capacity across multiple cycles. These findings reinforce the suitability of granulated cellulose CELLETS® 200 for organic pollutants adsorption in fixed-bed systems tailored to industrial effluents.

Conclusion & Outlook

The investigation confirms that granulated cellulose CELLETS® 200 for organic pollutants adsorption offers a sustainable, efficient biosorbent option for fixed-bed column processes, particularly in the removal of indelible dye molecules from pharmaceutical wastewater. The combination of green material sourcing, predictable and scalable performance, low hydraulic resistance, and reusability highlights CELLETS® 200 as a practical alternative to conventional adsorbents like activated carbon.

Future research should explore surface functionalization—such as the introduction of carboxyl or amine groups—to improve selectivity and capacity for various organic pollutants, including pharmaceutical remnants beyond dyes. Pilot-scale validations using actual industrial effluents, alongside techno-economic assessments and lifecycle analyses, will be essential to confirm the feasibility and environmental benefits of integrating CELLETS® 200 into full-scale wastewater treatment operations.

By showcasing granulated cellulose CELLETS® 200 for organic pollutants adsorption, this study advances the dialogue on sustainable biosorbents in fixed-bed systems, offering a strong foundation for both academic and industrial uptake of cellulose-based solutions in water treatment.

References

[1] Separations 2023, 10(2), 143; https://doi.org/10.3390/separations10020143 (PDF)